<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004466.pub2" GROUP_ID="VASC" ID="355003040314463566" MERGED_FROM="" MODIFIED="2012-08-12 08:25:39 +0100" MODIFIED_BY="Alma Adler" NOTES="&lt;p&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.2&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-08-12 08:25:01 +0100" NOTES_MODIFIED_BY="Alma Adler" REVIEW_NO="0223" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="5.0">
<COVER_SHEET MODIFIED="2012-08-12 08:25:39 +0100" MODIFIED_BY="Alma Adler">
<TITLE>Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft</TITLE>
<CONTACT MODIFIED="2012-08-12 08:25:39 +0100" MODIFIED_BY="Alma Adler"><PERSON ID="787BAF7382E26AA200C1C7C4BD41E183" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Eliane</FIRST_NAME><MIDDLE_INITIALS>RFS</MIDDLE_INITIALS><LAST_NAME>Freitas</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Physical Therapy</POSITION><EMAIL_1>elianefe@sercomtel.com.br</EMAIL_1><ADDRESS><DEPARTMENT>Physical Therapy Department</DEPARTMENT><ORGANISATION>UNOPAR / Centro Cochrane do Brasil</ORGANISATION><ADDRESS_1>Rua Belo Horizonte, 540 - apto 11</ADDRESS_1><CITY>Londrina</CITY><ZIP>86 020 060</ZIP><REGION>Parana</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 43 9995 1354</PHONE_1><PHONE_2>+55 43 3324 0492</PHONE_2><FAX_1>+55 43 3324 0492</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-08-12 08:25:39 +0100" MODIFIED_BY="Alma Adler"><PERSON ID="787BAF7382E26AA200C1C7C4BD41E183" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Eliane</FIRST_NAME><MIDDLE_INITIALS>RFS</MIDDLE_INITIALS><LAST_NAME>Freitas</LAST_NAME><SUFFIX>PhD</SUFFIX><POSITION>Physical Therapy</POSITION><EMAIL_1>elianefe@sercomtel.com.br</EMAIL_1><ADDRESS><DEPARTMENT>Physical Therapy Department</DEPARTMENT><ORGANISATION>UNOPAR / Centro Cochrane do Brasil</ORGANISATION><ADDRESS_1>Rua Belo Horizonte, 540 - apto 11</ADDRESS_1><CITY>Londrina</CITY><ZIP>86 020 060</ZIP><REGION>Parana</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 43 9995 1354</PHONE_1><PHONE_2>+55 43 3324 0492</PHONE_2><FAX_1>+55 43 3324 0492</FAX_1></ADDRESS></PERSON><PERSON ID="9639" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Bernardo</FIRST_NAME><MIDDLE_INITIALS>GO</MIDDLE_INITIALS><LAST_NAME>Soares</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>bgosoares@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Brazilian Cochrane Centre</DEPARTMENT><ORGANISATION>Universidade Federal de São Paulo</ORGANISATION><ADDRESS_1>Rua Pedro de Toledo 598</ADDRESS_1><CITY>São Paulo</CITY><ZIP>04039-001</ZIP><REGION>São Paulo</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 11 5575 2970</PHONE_1><FAX_1>+55 11 5579 0469</FAX_1></ADDRESS></PERSON><PERSON ID="13813" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jefferson</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Cardoso</LAST_NAME><SUFFIX>PT, PhD.PAIFIT</SUFFIX><EMAIL_1>jeffcar@uel.br</EMAIL_1><EMAIL_2>jeffcar@hotmail.com</EMAIL_2><MOBILE_PHONE>55 43 9996.4476</MOBILE_PHONE><ADDRESS><DEPARTMENT>Research Group, Laboratory of Biomechanics and Clinical Epidemiology</DEPARTMENT><ORGANISATION>Universidade Estadual de Londrina</ORGANISATION><ADDRESS_1>Av. Robert Koch 60</ADDRESS_1><CITY>Londrina</CITY><ZIP>86038-350</ZIP><REGION>PR</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>55 43 3371 2649</PHONE_1><PHONE_2>55 43 9996 4476</PHONE_2><FAX_1>55 43 3371 2459</FAX_1></ADDRESS></PERSON><PERSON ID="37061659393720431449110204144538" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Álvaro</FIRST_NAME><MIDDLE_INITIALS>N</MIDDLE_INITIALS><LAST_NAME>Atallah</LAST_NAME><EMAIL_1>alvaro.atallah@gmail.com</EMAIL_1><EMAIL_2>atallahmbe@uol.com.br</EMAIL_2><ADDRESS><DEPARTMENT>Brazilian Cochrane Centre</DEPARTMENT><ORGANISATION>Universidade Federal de São Paulo</ORGANISATION><ADDRESS_1>1 Rua Pedro de Toledo, 598</ADDRESS_1><CITY>São Paulo</CITY><ZIP>04038-000</ZIP><REGION>São Paulo</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 21 55 75 29 70</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-07-04 08:02:53 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="31" MONTH="7" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="7" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="7" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2012-08-12 08:25:01 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-07-16 10:24:26 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="7" YEAR="2011"/>
<DESCRIPTION>
<P>Two new outcomes were included: respiratory muscle strength reported by <LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK> and functional capacity by <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2012-08-12 08:25:01 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="7" YEAR="2011"/>
<DESCRIPTION>
<P>Of 366 additional references found in the update of this review, two new trials were included (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>; <LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>). One study which had been excluded in the previous review, was included due to additional data being presented (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>). Results remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-11-27 19:51:05 +0000" MODIFIED_BY="[Empty name]"/>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Federal University of São Paulo</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>University of Northern Paraná (UNOPAR)</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-07-04 08:45:39 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-07-04 08:08:45 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2011-07-17 22:28:58 +0100" MODIFIED_BY="[Empty name]">The use of incentive spirometry for preventing pulmonary complications in adults people undergoing coronary artery bypass graft surgery</TITLE>
<SUMMARY_BODY MODIFIED="2012-07-04 08:08:45 +0100" MODIFIED_BY="[Empty name]">
<P>Breathing complications after coronary artery bypass graft (CABG) surgery increases hospital stay and is with associated high healthcare costs. CABG may interfere with the lungs, causing sections of them to collapse which may lead to pneumonia. Re-inflating areas of the collapsed lung may be done by a device - an incentive spirometer - that reinforces a pattern of breathing which prevents and reverses the process. This device is used alone or in combination with other physiotherapy techniques.</P>
<P>This update included 592 participants from seven studies (two new and one that had been excluded in the previous 2007 review). We found evidence from four small trials that incentive spirometry offers no advantage over standard post-surgical physical therapy, or preoperative education in preventing breathing complications and pneumonia, improving lung function, or shortening length of hospital stay in patients undergoing CABG. Bigger and better designed trials are needed to determine if there is any role for incentive spirometry.<BR/>
</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-07-04 08:07:03 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-11-27 22:13:42 +0000" MODIFIED_BY="[Empty name]">
<P>Incentive spirometry (IS) is a treatment technique that uses a mechanical device to reduce pulmonary complications during postoperative care. This is an update of a Cochrane review first published in 2007.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-01-16 06:42:42 +0000" MODIFIED_BY="[Empty name]">
<P>Update the previously published systematic review to compare the effects of IS for preventing postoperative pulmonary complications in adults undergoing coronary artery bypass graft (CABG).</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-04-21 22:31:34 +0100" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL and DARE on <I>The Cochrane Library </I>(Issue 2 of 4 2011), MEDLINE OVID (1948 to May 2011), EMBASE (1980 to Week 20 2011), LILACS (1982 to July 2011) , the Physiotherapy Evidence Database (PEDro) (1980 to July 2011), Allied &amp; Complementary Medicine (AMED) (1985 to May 2011), CINAHL (1982 to May 2011).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-07-17 20:44:45 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials comparing IS with any type of prophylactic physiotherapy for prevention of postoperative pulmonary complications in adults undergoing CABG.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-06-11 14:15:41 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers independently evaluated trial quality using the guidelines of the Cochrane Handbook for Systematic Reviews and extracted data from included trials. For continuous outcomes, we used the generic inverse variance method for meta-analysis and for dichotomous data we used the Peto Odds Ratio.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-07-04 08:06:49 +0100" MODIFIED_BY="[Empty name]">
<P>This update included 592 participants from seven studies (two new and one that had been excluded in the previous review in 2007. There was no evidence of a difference between groups in the incidence of any pulmonary complications and functional capacity between treatment with IS and treatment with physical therapy, positive pressure breathing techniques (including continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP) and intermittent positive pressure breathing (IPPB), active cycle of breathing techniques (ACBT) or preoperative patient education. Patients treated with IS had worse pulmonary function and arterial oxygenation compared with positive pressure breathing. Based on these studies there was no improvement in the muscle strength between groups who received IS demonstrated by maximal inspiratory pressure and maximal expiratory pressure.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-07-04 08:07:03 +0100" MODIFIED_BY="[Empty name]">
<P>Our update review suggests there is no evidence of benefit from IS in reducing pulmonary complications and in decreasing the negative effects on pulmonary function in patients undergoing CABG. In view of the modest number of patients studied, methodological shortcomings and poor reporting of the included trials, these results should still be interpreted cautiously. An appropriately powered trial of high methodological rigour is needed to determine if there are patients who may derive benefit from IS following CABG.<BR/>
</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-07-04 08:45:39 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-07-04 08:12:08 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Description of the condition</B>
</P>
<P>
<I>The burden of postoperative pulmonary complications following cardiac surgery</I>
<BR/>Despite several advances in the treatment of coronary artery disease, many patients, especially those with multivessel disease and complex anatomies, benefit greatly when subjected to surgical treatment (<LINK REF="REF-Mohr-2011" TYPE="REFERENCE">Mohr 2011</LINK>). The coronary artery bypass graft (CABG) surgery is the routine procedure for the treatment of patients who present with symptoms of myocardial ischemias (<LINK REF="REF-Keenan-2005" TYPE="REFERENCE">Keenan 2005</LINK>), and accounts for more resources expended in cardiovascular medicine than any other single procedure (<LINK REF="REF-ACC_x002f_AHA-1999" TYPE="REFERENCE">ACC/AHA 1999</LINK>). Annually, about one million surgeries are carried out in the world (<LINK REF="REF-Keenan-2005" TYPE="REFERENCE">Keenan 2005</LINK>). The patients receiving CABG present a relatively high risk of developing pulmonary complications, such as atelectasia, pneumonia and pleural effusion. These complications (including mortality) increase the time of hospitalisation and the necessity of financial resources (<LINK REF="REF-Pasquina-2003" TYPE="REFERENCE">Pasquina 2003</LINK>; <LINK REF="REF-Ferguson-1999" TYPE="REFERENCE">Ferguson 1999</LINK>; <LINK REF="REF-Lawrence-1995" TYPE="REFERENCE">Lawrence 1995</LINK>). Transoperatory factors, such as general anaesthesia, pulmonary modifications after extracorporeal circulation, utilization of internal mammary artery as well as postoperative pain, are factors that contribute to the occurrence of pulmonary complications(<LINK REF="REF-Groeneveld-2007" TYPE="REFERENCE">Groeneveld 2007</LINK>; <LINK REF="REF-Groeneveld-2006" TYPE="REFERENCE">Groeneveld 2006</LINK>; <LINK REF="REF-Ferguson-1999" TYPE="REFERENCE">Ferguson 1999</LINK>; <LINK REF="REF-Kips-1997" TYPE="REFERENCE">Kips 1997</LINK>; <LINK REF="REF-Mohr-1996" TYPE="REFERENCE">Mohr 1996</LINK>; <LINK REF="REF-Berrizbetia-1989" TYPE="REFERENCE">Berrizbetia 1989</LINK>; <LINK REF="REF-Hallbook-1984" TYPE="REFERENCE">Hallbook 1984</LINK>). Therefore efforts have been made during the last decade to identify patients with the greatest chance of developing complications, and to find techniques to prevent such complications (<LINK REF="REF-Ferguson-1999" TYPE="REFERENCE">Ferguson 1999</LINK>).</P>
<P>
<I>Risk factors for postoperative pulmonary complications</I>
<BR/>Manifold variables, whether patient-related (for example age, constitution, or concomitant pulmonary disease) or care-related (for example type of surgery, anaesthesia or analgesia), are supposed to have an impact on the efficacy of pulmonary function following surgery (<LINK REF="REF-Groeneveld-2007" TYPE="REFERENCE">Groeneveld 2007</LINK>; <LINK REF="REF-Groeneveld-2006" TYPE="REFERENCE">Groeneveld 2006</LINK>; <LINK REF="REF-Weindler-2001" TYPE="REFERENCE">Weindler 2001</LINK>; <LINK REF="REF-Ferguson-1999" TYPE="REFERENCE">Ferguson 1999</LINK>). As the average age of patients undergoing CABG is increasing (due to several factors, including the improvement of therapeutic effectiveness) the effect of age on the incidence of postoperative pulmonary complications is significant (<LINK REF="REF-Mortasawi-2004" TYPE="REFERENCE">Mortasawi 2004</LINK>; <LINK REF="REF-Hulzebos-2003" TYPE="REFERENCE">Hulzebos 2003</LINK>; <LINK REF="REF-Weinstein-1987" TYPE="REFERENCE">Weinstein 1987</LINK>). Other risk factors generally present in patients with coronary syndromes, including smoking, obesity, physical inactivity, diabetes, raised high-density lipoprotein levels, systolic hypertension, chronic obstructive pulmonary disease, pain and previus reduction of pulmonary function, also increase the risk of postoperative pulmonary complications (<LINK REF="REF-Hulzebos-2003" TYPE="REFERENCE">Hulzebos 2003</LINK>; <LINK REF="REF-Daganou-1998" TYPE="REFERENCE">Daganou 1998</LINK>; <LINK REF="REF-Higgins-1988" TYPE="REFERENCE">Higgins 1988</LINK>; <LINK REF="REF-Kannel-1980" TYPE="REFERENCE">Kannel 1980</LINK>; <LINK REF="REF-Kannel-1984" TYPE="REFERENCE">Kannel 1984</LINK>; <LINK REF="REF-Kannel-1985" TYPE="REFERENCE">Kannel 1985</LINK>; <LINK REF="REF-Kannel-1986" TYPE="REFERENCE">Kannel 1986</LINK>; <LINK REF="REF-Kannel-1987" TYPE="REFERENCE">Kannel 1987</LINK>; <LINK REF="REF-Wilking-1988" TYPE="REFERENCE">Wilking 1988</LINK>).</P>
<P>
<B>Description of the intervention</B>
</P>
<P>
<I>Interventions to reduce postoperative pulmonary complications</I>
<BR/>In 1989, in order to guide practice, a consensus conference on perioperative cardiorespiratory physical therapy (modelled on the National Institutes of Health consensus methodology) was held in Canada (<LINK REF="REF-CPA-1990" TYPE="REFERENCE">CPA 1990</LINK>). Canadian hospitals with more than 300 beds were surveyed to determine current perioperative cardiorespiratory practice. This survey, with minimal modification to reflect changes in surgical techniques, was repeated in 1997 to determine practice patterns and to document changes since 1990. In the years since the consensus conference, more studies on perioperative physical therapy have been published and surgical techniques have changed (<LINK REF="REF-Brooks-2001" TYPE="REFERENCE">Brooks 2001</LINK>). Incentive spirometry (IS) is a widely used technique for the prophylaxis and treatment of respiratory complications in postsurgical patients (<LINK REF="REF-Cavenaghi-2011" TYPE="REFERENCE">Cavenaghi 2011</LINK>; <LINK REF="STD-Ferreira-2010" TYPE="STUDY">Ferreira 2010</LINK>; <LINK REF="STD-Renault-2009" TYPE="STUDY">Renault 2009</LINK>;<LINK REF="REF-Renault-2008" TYPE="REFERENCE">Renault 2008</LINK>; <LINK REF="STD-Haeffener-2008" TYPE="STUDY">Haeffener 2008</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>; <LINK REF="REF-Overend-2001" TYPE="REFERENCE">Overend 2001</LINK>; <LINK REF="REF-Wattie-1998" TYPE="REFERENCE">Wattie 1998</LINK>; <LINK REF="REF-Jenkins-1986" TYPE="REFERENCE">Jenkins 1986</LINK>; <LINK REF="REF-O_x0027_Donohue-1985" TYPE="REFERENCE">O'Donohue 1985</LINK>). However, several publications have questioned the effectiveness of IS (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Gale-1980" TYPE="STUDY">Gale 1980</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Oulton-1981" TYPE="STUDY">Oulton 1981</LINK>; <LINK REF="REF-Stiller-1994" TYPE="REFERENCE">Stiller 1994</LINK>; <LINK REF="STD-Stock-1984" TYPE="STUDY">Stock 1984</LINK>), and the use of the technique is the subject of debate (<LINK REF="REF-Restrepo-2011" TYPE="REFERENCE">Restrepo 2011</LINK>; <LINK REF="REF-Freitas-2007" TYPE="REFERENCE">Freitas 2007</LINK>; <LINK REF="REF-Pasquina-2003" TYPE="REFERENCE">Pasquina 2003</LINK>; <LINK REF="REF-Brooks-2001" TYPE="REFERENCE">Brooks 2001</LINK>; <LINK REF="REF-Overend-2001" TYPE="REFERENCE">Overend 2001</LINK>).</P>
<P>
<B>How the intervention might work</B>
</P>
<P>The treatment utilizes an incentive spirometer, a mechanical device developed to reduce pulmonary complications during postoperative care (<LINK REF="REF-Chuter-1990" TYPE="REFERENCE">Chuter 1990</LINK>). It was developed to imitate natural sighing and yawning, and encourages the patient, through visual and/or audio feedback (<LINK REF="REF-Bartlett-1973" TYPE="REFERENCE">Bartlett 1973</LINK>), to maintain inspiration for a prolonged period, using slow inspiration and deep breaths (<LINK REF="REF-AARC-1991" TYPE="REFERENCE">AARC 1991</LINK>; <LINK REF="REF-Bartlett-1970" TYPE="REFERENCE">Bartlett 1970</LINK>; <LINK REF="REF-Craven-1974" TYPE="REFERENCE">Craven 1974</LINK>; <LINK REF="REF-Meyers-1975" TYPE="REFERENCE">Meyers 1975</LINK>; <LINK REF="REF-Petz-1979" TYPE="REFERENCE">Petz 1979</LINK>).</P>
<P>
<B>Why it is important to do this review</B>
</P>
<P>Due to its low cost, incentive spirometers are widely used in hospitals. They are used for treating and preventive purposes regarding pulmonary complications. This device works with visual stimulation to deep inspiration and is largely used by patients in post operatory periods of abdominal and thoracic surgery (<LINK REF="REF-Agostini-2008" TYPE="REFERENCE">Agostini 2008</LINK>). Despite its low cost, the routine use of IS in CABG will add to the cost of care. Studies evaluating the effectiveness of IS in patients who have had cardiac surgery, however, have been unable to demonstrate the superiority of IS over other techniques (<LINK REF="REF-Restrepo-2011" TYPE="REFERENCE">Restrepo 2011</LINK>; <LINK REF="REF-Freitas-2007" TYPE="REFERENCE">Freitas 2007</LINK>; <LINK REF="REF-Pasquina-2003" TYPE="REFERENCE">Pasquina 2003</LINK>; <LINK REF="REF-Brooks-2001" TYPE="REFERENCE">Brooks 2001</LINK>; <LINK REF="REF-Overend-2001" TYPE="REFERENCE">Overend 2001</LINK>;<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>;<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>).</P>
<P>Since the last published review, we have included two new outcomes, maximal expiratory pressure (maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP)) and the six minute walk test (6MWT). This is because the peak of postoperative diaphragm dysfunction, with a decrease in its strength, occurs between two to eight hours postoperatively, with a return to pre-operative values occurring within approximately two weeks. These alterations occur in response to the surgical procedure and can progress to respiratory complications when they modify the initially predicted course for postoperative recovery. The complications are related to the decrease of the contractile capacity of the diaphragm, directly represented by MIP and MEP decrease (<LINK REF="REF-Siafakas-1999" TYPE="REFERENCE">Siafakas 1999</LINK>; <LINK REF="REF-Chandler-1984" TYPE="REFERENCE">Chandler 1984</LINK>), and the 6MWT. They have now become a common method to determine functional capacity (<LINK REF="REF-ATS-2002" TYPE="REFERENCE">ATS 2002</LINK>). For these reasons, it is important to have the best evidence of the beneficial effects of IS after CABG before recommendations for use are applied uniformly. Therefore an updated systematic review evaluating the effectiveness of IS in patients undergoing CABG is necessary.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-07-04 08:12:45 +0100" MODIFIED_BY="[Empty name]">
<P>To update the previously published systematic review to compare the effects of IS in preventing postoperative pulmonary complications in adults undergoing CABG. Where available, information is presented on the efficacy of IS in the presence or absence of other treatment or IS associated with other techniques.</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-07-04 08:22:39 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-07-04 08:15:50 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>Randomized controlled trials (RCTs).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-01-16 15:16:15 +0000" MODIFIED_BY="[Empty name]">
<P>Trials including patients over 18 years of age undergoing CABG, not associated with valve replacements or other procedures.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-07-04 08:14:43 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>
<I>Intervention group</I>
</B>
<BR/>
</P>
<P>IS that allows the patients to accomplish breathing exercises emphasising inspiration with sustained maximal inhalation. The literature search included patients undergoing CABG treated with IS compared with other techniques of physiotherapy treatment for prophylaxis of pulmonary complications. For the purposes of this update, it was necessary to group these variations within broad definitions of the treatment modalities.</P>
<P>
<B>
<I>Control group</I>
</B>
</P>
<P>IS was compared with other techniques as described below:</P>
<P>
<U>
<I>Standard postsurgical physical therapy (PPT)</I>
</U>
</P>
<P>This included any combination of the following: manual interventions (chest vibration, percussion, chest shaking), forced expiratory with the glottis open (huffing), coughing with sternal support, active exercises of the upper and lower limbs, sitting in a chair, walking, and aerosol therapy.</P>
<P>
<U>
<I>Continuous positive airway pressure (CPAP) mask therapy</I>
</U>
</P>
<P>Is a spontaneous ventilatory mode maintaining a supra-atmospheric pressure in the lung.</P>
<P>
<U>
<I>Intermittent positive pressure breathing (IPPB) </I>
</U>
</P>
<P>Is a spontaneous ventilatory mode with of periodic intermittent positive pressure breathing.</P>
<P>
<U>
<I>Bilevel positive airway pressure (BiPAP or NIV-2P) mask therapy</I>
</U>
</P>
<P>Is a barometric ventilatory mode the action of which is determined by the difference between Inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP)</P>
<P>The comparisons of IS with positive pressure breathing techniques (CPAP, IPPB, BiPAP or NIV-2P) plus standard postsurgical physical therapy were also included.</P>
<P>
<U>
<I>Active cycle of breathing techniques (ACBT)</I>
</U>
</P>
<P>ACBT consisted of one to two breathing control breaths, three thoracic expansion exercises follows by a three second breath hold at the end of deep inspiration, and forced expiration technique including one to two breathing control breaths combined with one to two huffs.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-07-04 08:15:50 +0100" MODIFIED_BY="[Empty name]">
<P>RCTs reporting any of the following short- or long-term outcomes were eligible for inclusion.</P>
<P>
<B>
<I>Primary outcomes</I>
</B>
<BR/>1. Atelectasis: radiographic, tomographic or bronchoscopic diagnosis and/or clinical signs with acute respiratory symptoms, for example dyspnoea, cough, abnormal lung sounds.<BR/>2. Acute respiratory infection (pneumonia): radiographic diagnosis and/or clinical signs of acute respiratory symptoms for example purulent tracheobronchial secretion, fever (&gt;38°C) or increased circulating leucocytes (&gt;10,000/mm³).</P>
<P>3. Total mortality from respiratory causes: data of the necropsy or clinical inference.<BR/>
</P>
<P>
<B>
<I>Secondary outcomes</I> </B>
<BR/>1. Vital capacity (ml)</P>
<P>2. Forced expiratory volume in one second (ml) (FEV<SUB>1</SUB>).<BR/>2. Arterial Oxygenation <I>(Partial pressure of arterial oxygen per inspired oxygen fraction (PaO<SUB>2</SUB>/FiO<SUB>2</SUB>). </I>
</P>
<P>3. Postoperative days in hospital.</P>
<P>3. Respiratory muscle strength: MIP maximal expiratory pressure MEP.</P>
<P>4. Functional capacity: 6MWT.</P>
<P>5. Perceived quality of life.</P>
<P>6. Economic costs.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-06-28 09:48:52 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Eletronic searches</B>
</P>
<P>The original searches from December 2004 (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>) have been updated and were re-run in August 2009 and May 2011 (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) on <I>The Cochrane Library </I>(Issue 2 of 4, 2011, DVD), MEDLINE OVID (1948 to May Week 2 2011), EMBASE OVID (1980 to 2011 Week 20), Allied &amp; Complementary Medicine (AMED) (1985 to May 2011), CINAHL (1982 to May 2011) and Database of Abstracts of Reviews of Effects (DARE) on <I>The Cochrane Library </I>(Issue 2 of 4, 2011, DVD) on 23 May 2011. The searches of LILACS (1982 to July 2011) and the Physiotherapy Evidence Database (PEDro) (1980 to July 2011) have last been run in July 2011.</P>
<P>We used the recommended search strategy for identifying RCTs in MEDLINE for our search in 2004 from the Cochrane Handbook (<LINK REF="REF-Clarke-2001" TYPE="REFERENCE">Clarke 2001</LINK>). In 2011 we used the updated Cochrane RCT filter ( <LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>) for MEDLINE and EMBASE. No language restrictions were applied to the searches.</P>
<P>
<B>Searching other resources</B>
</P>
<P>Annual meeting abstracts of the American Heart Association, American College of Cardiology, and European Society of Cardiology were also searched from 1996 to July 2011. We searched the references lists of identified studies and other relevant articles and contacted authors of relevant studies to request details of unpublished or ongoing investigations. We used The Cochrane Handbook of Systematic Reviews (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>) recommended search strategy for identifying RCTs .</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-07-04 08:22:39 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Selection of studies </B>
</P>
<P>For the update, titles or abstracts of citations retrieved from the literature search were screened for duplicates by the Cochrane Heart Group and lists of potential studies for inclusion in the review were sent to the review authors. All studies that were not randomised controlled trials or that clearly did not fit the inclusion criteria were excluded. Where there was uncertainty as to the nature of the trial or randomisation of participants, a letter was sent to the first named author at the institution stated on the paper. The full text of all other citations were reviewed independently by four review authors to assess eligibility.</P>
<P>
<B>Data extraction and management</B>
<BR/>Data were extracted independently by the four authors (ERFSF, BGOS, JRC and ANA). For each included study, all data were extracted and recorded by the review author. Information on the demographics of the study and inclusion and exclusion criteria were detailed. Treatment interventions and durations were listed together with details of any control groups and a full list of outcome measures for each study. This is presented in a tabular format in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. <I>
<BR/>
</I>
</P>
<P>
<B>Assessment of risk bias in included studies</B>
<BR/>We followed the guidelines of the Cochrane Reviewers' Handbook (<LINK REF="REF-Clarke-2003" TYPE="REFERENCE">Clarke 2003</LINK>,<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The reviewers (ERFSF, BGOS, JRC and ANA) independently assessed methodological quality of selected studies and assessment of risk bias in included studies, including adequacy of allocation concealment, which was ranked as 'Yes'- low risk of bias, 'Unclear' risk of bias and 'No'-high risk of bias. Any differences of opinion were resolved by discussion and consensus.</P>
<P>All the included studies randomised participants into treatment groups (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>; <LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>). Random number tables were used by one study (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>) using computer-generated random number table, drawing lots by one (<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>). Despite using computer-generated random number table in the one study (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>), it should be noted that, the numbers in the treated and control groups in this study differ considerably.  It would appear that in all of the studies, patients were randomised consecutively after fulfilling any inclusion criteria. This was essential to reduce bias at the allocation stage. Data on inclusion and exclusion criteria are presented in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. One study (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>) reported ten patients exclusions after randomisation.</P>
<P>The patients in these studies were not blinded to the types of treatments, therefore all of the studies had a great potential for bias. The measurement of outcome measures was non-biased, because the assessors were blinded in all studies,</P>
<P>
<B>Measures of treatment effect</B>
<BR/>We had hoped to find sufficient trials to carry out a meta-analysis of all findings using RevMan-5 software. Owing to limitations in the published material we have conducted a part of the narrative form review and have presented dichotomous outcomes using Peto odds ratios (OR), and 95% confidence intervals (CI). Continuous variables have been expressed as the mean change from baseline to follow up, and the standard deviation difference from baseline to follow up for each comparison group. Where standard deviation differences were not reported allowance was made within patient correlation from baseline to follow up measurement, using the correlation coefficient between the two (see Cochrane Heart Group web site and (<LINK REF="REF-Follmann-1992" TYPE="REFERENCE">Follmann 1992</LINK>) for details).</P>
<P>
<B>Unit of treatment effect</B>
</P>
<P>Seven RCTs were included in this update, comparing several different outcomes.</P>
<P>
<B>Dealing with missing data</B>
</P>
<P>All individual studies would be analysed according to intention to treat analysis.</P>
<P>
<B>Data synthesis</B>
</P>
<P>When possible, we grouped studies on specific treatment techniques for the purpose of meta-analysis. This facilitated comparisons between specific IS treatment, as well as comparisons with other techniques.</P>
<P>
<B>Subgroup analysis and investigation of heterogeneity</B>
</P>
<P>Due to the limited number of trials assessing different treatment options, statistical techniques for looking at heterogeneity of data, publication bias (funnel plot), and subgroup analysis were not applied.</P>
<P>
<B>Sensitivity analysis</B>
</P>
<P>Due to the limited number of trials we did not undertake sensitivity analysis.</P>
<P>
<B>Data analysis</B>
</P>
<P>Results were expressed as Peto OR with 95% CI for dichotomous variables. Results for continuous variables were expressed as mean differences (MD) with 95% CI.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-07-04 08:34:29 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-07-04 08:29:52 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Results of the search </B>
<I>
<BR/>
</I>In this update 366 new references were identified after duplicates were removed, totaling 1148 potentially relevant publications (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) (<LINK REF="REF-Moher-1999" TYPE="REFERENCE">Moher 1999</LINK>). After reading titles and abstracts we excluded 992 papers (generally due to lack of suitability of study design or intervention), and 156 papers were retrieved for further evaluation. Subsequently 137 papers were excluded because they did not meet inclusion criteria. Nineteen studies were eligible for inclusion and detailed assessment, however, subsequently 12 studies were excluded (<LINK REF="STD-Vraciu-1977" TYPE="STUDY">Vraciu 1977</LINK>; <LINK REF="STD-Iverson-1978" TYPE="STUDY">Iverson 1978</LINK>; <LINK REF="STD-Gale-1980" TYPE="STUDY">Gale 1980</LINK>; <LINK REF="STD-Oulton-1981" TYPE="STUDY">Oulton 1981</LINK>; <LINK REF="STD-Paul-1981" TYPE="STUDY">Paul 1981</LINK>; <LINK REF="STD-Stock-1984" TYPE="STUDY">Stock 1984</LINK>; <LINK REF="STD-Rau-1988" TYPE="STUDY">Rau 1988</LINK>; <LINK REF="STD-Jenkins-1990" TYPE="STUDY">Jenkins 1990</LINK>; <LINK REF="STD-Mahler-1998" TYPE="STUDY">Mahler 1998</LINK>; <LINK REF="STD-Haeffener-2008" TYPE="STUDY">Haeffener 2008</LINK>; <LINK REF="STD-Renault-2009" TYPE="STUDY">Renault 2009</LINK>; <LINK REF="STD-Ferreira-2010" TYPE="STUDY">Ferreira 2010</LINK>), see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>.</P>
<P>We would like to emphasize that one study had been excluded from the previous review because the data had been presented in the form of graphs and illustrations. We have subsequently obtained this data and as such have included it in this review (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>).</P>
<P>
<B>Included studies</B>
</P>
<P>Seven RCTs met the inclusion criteria in this update (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>; <LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>) (see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>), providing a total of 592 patients. Five trials reported data on atelectasis (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>), four reported data on pneumonia (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>), five reported data on pulmonary function (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>), four reported data on partial pressure of oxygen and fractional inspired oxygen (PaO2/FiO2) (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>), one reported data on ventilatory muscle strength (MIP and MEP) (<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>). One study reported data on functional capacity (6MWT) (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>) and two on postoperative days in hospital (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>). The average group size was 34 patients (range 10-95 patients), and the range of follow-up was two to five days. </P>
<P>All trials excluded patients with unstable cardiac status, intubation time longer than 24 hours and patients who failed to co-operate. Two study only recruited male patients (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>), two studies excluded subjects with chronic obstructive pulmonary disease (<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>), one study excluded any subjects over the age of 70 (<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>), one study excluded smokers, a history of cerebrovascular accident, renal dysfunction requiring dialysis, use of immunosuppressive treatments during the 30 day period before surgery, cardiovascular instability or an aneurysm (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>). Thus, the population included in studies was of low surgical risk because studies excluded participants who took longer to wean off ventilators, pre-existing lung disease, undergoing emergent CABG surgery, and participants with postoperative cardiac neurological complications.</P>
<P>One study included patients undergoing CABG and valve replacement (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>), three studies included patients undergoing CABG with the use of internal mammary artery and saphenous vein (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>), and one study included patients undergoing elective CABG with the use of mammary arteries only (<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>).</P>
<P>The mean age of included patients ranged from 41 to 75 years, 516 patients were male (90.2%), and 76 patients were female (13.3%).</P>
<P>The trials were conducted between 1983 and 2007 in Europe (United Kingdom, Belgium, Finland), North America (Canada and USA), and Brazil.</P>
<P>
<B>Interventions </B>
<BR/>
</P>
<P>Two hundred and forty eight patients were allocated to IS and 344 patients were allocated to control. In four studies (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>;<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>) conventional physical therapy (typically considered as a type of generic postsurgical physiotherapy: e.g. early bed mobility, ambulation, basic deep breathing, and coughing exercises) or early mobilization was given to both the intervention and the control groups. Three trials (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>) compared IS versus positive airway pressure techniques (CPAP, BiPAP and IPPB) and in two groups (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>) IS was given to both the intervention group and the control group plus physical therapy. Two trials (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>;<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>) compared IS alone, one study versus conventional physical therapy intervention and versus preoperative education (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>) and other study versus IPPB (<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>). One trial (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>) compared the IS plus conventional physical therapy versus active cycle of breathing techniques (ACBT).<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>
</P>
<P>The incentive spirometry intervention ranged from 5 to 10 breaths repeated every two hours or 10 breaths repeated every one to two hours .</P>
<P>
<B>Excluded studies</B>
</P>
<P>A total of 12 studies were excluded (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>); four did not have relevant end-points (<LINK REF="STD-Mahler-1998" TYPE="STUDY">Mahler 1998</LINK>; <LINK REF="STD-Oulton-1981" TYPE="STUDY">Oulton 1981</LINK>; <LINK REF="STD-Rau-1988" TYPE="STUDY">Rau 1988</LINK>; <LINK REF="STD-Vraciu-1977" TYPE="STUDY">Vraciu 1977</LINK>); one was a quasi-randomised trial (<LINK REF="STD-Iverson-1978" TYPE="STUDY">Iverson 1978</LINK>); one was a non-controlled trial (<LINK REF="STD-Paul-1981" TYPE="STUDY">Paul 1981</LINK>); one was a duplicate report (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>); two combined CABG with other interventions and did not present the results for CABG separately (<LINK REF="STD-Gale-1980" TYPE="STUDY">Gale 1980</LINK>; <LINK REF="STD-Stock-1984" TYPE="STUDY">Stock 1984</LINK>); one did not present individual results for each group (<LINK REF="STD-Renault-2009" TYPE="STUDY">Renault 2009</LINK>), and two combined IS connected with EPAP and showed the results in form of graphs or illustrations (<LINK REF="STD-Haeffener-2008" TYPE="STUDY">Haeffener 2008</LINK>; <LINK REF="STD-Ferreira-2010" TYPE="STUDY">Ferreira 2010</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-06-13 03:40:55 +0100" MODIFIED_BY="[Empty name]">
<P>Summary with details of the quality assessment are given in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>; <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
<P>The risk of bias in the included studies were assessed by two review authors. Only one study reported random sequence using a computer-generated random number table <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>. No study reported adequate allocation concealment and sequence generation. Two studies (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>) described blinding the observer. Others forms of blinding were not found (participants and professionals). Given the interventions being studied, it would not have been feasible to have blinded the participants or carers to the treatment group. <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK> had incomplete outcome data. <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK> had not applied intention to treat analysis. All included studies (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>) had adequate follow-ups.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-07-04 08:34:29 +0100" MODIFIED_BY="[Empty name]">
<P>Seven studies involving 592 participants were included in this update of review (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>; <LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>)</P>
<P>
<U>
<B>Primary outcomes</B>
</U>
<B>
<BR/>
</B>
<BR/>
<B>
<I>Pulmonary complications </I>
</B>
</P>
<P>
<U>
<I>Atelectasis </I>
</U>
<BR/>Five trials involving 502 subjects reported this outcome (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>), with 213 (42.4%) allocated to IS and 289 (57.6%) to other techniques <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>. Due to the variability of the comparison we were unable to pool the five trials. There was little evidence of a reduction of atelectasis in any of the comparison groups. In two trials where patients received IS compared with conventional physical therapy, pooled analysis showed no effects between IS and conventional therapy <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>, <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>.</P>
<P>
<U>
<I>Acute respiratory infection (Pneumonia)</I>
</U>
<I> </I>
<BR/>Four trials reported this outcome (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>;<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>), involving 443 patients, with 184 (41.5%) allocated to IS and 259 (58.5%) to other techniques <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>. Again, due to the variability of the comparison we were unable to pool the four trials. In two trials where patients received IS compared with conventional physical therapy, pooled analysis showed no effects between IS and conventional therapy <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK> <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>
</P>
<P>
<U>
<I>Total mortality from respiratory causes</I>
</U>
</P>
<P>None of the included studies assessed this outcome.</P>
<P>
<U>
<B>Secondary outcomes</B>
</U>
</P>
<P>
<U>
<I>Vital capacity </I>
</U>
<BR/>Six trials reported vital capacity (<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>), involving 552 subjects with 231 (41.8%) allocated to IS and 321 (58.2%) to control groups <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>. In this analysis there was also a great variability of the comparison and we were unable to pool the six trials. However in three trials (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>) where patients received IS compared with conventional physical therapy, pooled analysis showed that there was no favourable effect from IS <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>, similar results were found when comparing IS with preoperative physiotherapy advice only <LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>. People that received treatment with IS had a smaller volume of vital capacity when compared to positive pressure breathing techniques with statistical significance (IS <I>versus</I> CPAP: P=0.01; IS <I>versus</I> BiPAP or NIV-2P: P=0.0002; IS vs IPPB P&lt; 0.00001) (<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>) <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>; <LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK>. One trial did not report the standard deviation (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>) and another trial presented vital capacity as a percentage and can not be analysed (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>).</P>
<P>
<U>
<I>Forced expiratory volume in one second (FEV<SUB>1</SUB>) </I>
</U>
<BR/>Five trials involving 500 subjects reported this outcome (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>; <LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>), with 228 (45.6%) allocated to IS and 272 (54.4%) to control groups <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>. Due to the variability of the comparison we were unable to pool the five trials. There was little evidence of a improvement of VEF<SUB>1</SUB> in any of the comparison groups. In three trials where patients received IS compared with conventional physical therapy (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>) <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK> <LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>, and in two trials where patients received IS compared with preoperative advice only (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>) <LINK REF="CMP-008.02" TYPE="ANALYSIS">Analysis 8.2</LINK>, pooled analysis showed no beneficial effect in favour from IS. People given IS plus physical therapy had a smaller FEV<SUB>1</SUB> compared with positive pressure breathing techniques (Is <I>versus</I> CPAP: P=0.0005 and IS <I>versus</I> BiPAP: P=0.007) (<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>). The FEV<SUB>1 </SUB>was presented as percentage in one trial and could not be analysed (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>).</P>
<P>
<U>
<I>Arterial Oxygenation (Partial pressure of arterial oxygen per inspired oxygen fraction (PaO<SUB>2</SUB>/FiO<SUB>2</SUB>) </I>
</U>
<BR/>Four trials involving 318 subjects reported this outcome (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>), with 124 (39,0%) allocated to IS and 194 (61.0%) to control groups <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>. People given IS had smaller PaO<SUB>2</SUB>/FiO<SUB>2</SUB> when compared with positive pressure breathing techniques (<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>) (IS <I>versus</I> BiPAP or NIV-2P: P=0.02; IS <I>versus</I> IPPB: P=0.0005). However, there was no difference between those receiving IS versus conventional physical therapy or preoperative physiotherapy advice only (<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>) or active cycle of breathing techniques (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>).</P>
<P>
<U>
<I>Respiratory muscle strength: MIP and MEP.</I>
</U>
</P>
<P>One study reported these outcomes involving 40 subjects, with 20 (50.0%) allocated to IS and 20 (50.0%) to control group that received IPPB (<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>) <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>. The group that received IPPB had better muscle strength assessed by MIP and MEP breathing when compared to the group receiving IS (MIP<I> </I>P=0.04; MEP P=0,07).</P>
<P>
<U>
<I>Functional Capacity - 6MWT</I>
</U>
</P>
<P>One trial involving 60 subjects used 6MWT as an outcome to assess functional capacity, with 30 (50.0%) allocated to IS and 30 (50.0%) to a control group that received active cycle of breathing techniques demonstrated no difference between treatment groups (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>) <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>
</P>
<P>
<U>
<I>Postoperative days in hospital</I>
</U>
<BR/>The postoperative days in hospital was reported in two trials (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>), involving 281 subjects, with 120 (42.7%) allocated to IS plus standard postsurgical physical therapy and 161 (57.3%) allocated to standard postsurgical physical therapy . In one study (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>) the average number of postoperative days in the IS plus physical therapy group was 9.0 days versus 9.7 days in those given standard postsurgical physical therapy. One study (<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>) evaluated only the stay in the intensive care united and the average number of IS group was 2.2 days versus 2.1 days in those CPAP and versus 2.1 days in those BiPAP or NIV-2P.</P>
<P>
<U>
<I>Economic cost</I>
</U>
</P>
<P>One study mentioned this outcome and demonstrated that the IS cost $7.25. This trial involved 185 subjects, with 90 (48.6%) allocated to IS and 95 (51.4%) to control group that received standard physical therapy (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>).</P>
<P>
<U>
<I>Perceived quality of life</I>
</U>
</P>
<P>Ferreira et al <LINK REF="STD-Ferreira-2010" TYPE="STUDY">Ferreira 2010</LINK> analysed of life quality, using the SF-36 and could not find any statistical differences in the majority on the assessed parameters between groups. The only domains which presented significant difference between group concerned the limitations in physical aspects, in which IS and EPAP group presented higher values in comparison to control group.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-07-04 08:44:28 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Summary of main results</B>
</P>
<P>This update review was set out to determine if there was any advantage of IS (a technique used for many years for preventing pulmonary complication after surgery) over other techniques. Studies comparing IS with other techniques, such as conventional physical therapy, preoperative physiotherapy advice only, CPAP, BiPAP or NIV-2P, IPPB and ACBT and physiotherapy advice only were included. The results of this update indicate insufficient evidence as to whether IS is effective for preventing postoperative pulmonary complications in adults undergoing CABG when compared with other techniques. Due to the variability of the comparisons we were unable to pool some trials. One of the major drawbacks of the reviewed literature is that the individual studies involved very small numbers of patients and each study considered only a limited number of outcome measures.</P>
<P>
<B>Outcomes</B>
</P>
<P>There was little evidence of a reduction in atelectasis and pneumonia and better pulmonary function in the subjects undergoing IS when compared with conventional physical therapy (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>). Only one trial (<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>) indicated that the IS was better in increasing respiratory muscle strength (MIP and MEP) than IPPB. However, other studies indicated that IS did not improve arterial oxygenation (PaO2/FiO2), VC and FEV1 than BiPAP (NIV-2P) (<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>) and that IPPB and CPAP were better at improving FEV1 than IS (<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>).</P>
<P>To evaluate functional capacity, the 6MWT was performed in one trial, which concluded that between the groups that underwent IS versus ACBT the functional capacity was well preserved (<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>).</P>
<P>The cost-effectiveness of IS is of interest and was considered in only one trial (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>). This study concluded that, if IS was proven to be as effective as physical therapy, it would be an economic alternative. Stock et al (<LINK REF="STD-Stock-1984" TYPE="STUDY">Stock 1984</LINK>) reported that IS offers no advantage over coughing and deep breathing, and there is the expense of acquiring a spirometer. Pasquina et al (Pasquina 2003) reported from their systematic review that the average daily cost of labour for each patients was &#8364;6 for IS. However Overend et al (<LINK REF="REF-Overend-2001" TYPE="REFERENCE">Overend 2001</LINK>) have pointed out that the cost of IS is affected by many factors, including the type of spirometer and the method used (for instance single use versus re-use following sterilization). If there was no difference in the effectiveness of IS technique over other techniques, the spirometer would add costs that could be neglected in this context.</P>
<P>Perveived quality of life considered in only one study (<LINK REF="STD-Ferreira-2010" TYPE="STUDY">Ferreira 2010</LINK>) which indicated that IS may improve physical outcomes but the evidence is weak.</P>
<P>
<B>Overall completeness and applicability of evidence</B>
</P>
<P>The therapeutic efficacy of IS is still being tested and much discussed in the literature (<LINK REF="REF-Pinheiro-2011" TYPE="REFERENCE">Pinheiro 2011</LINK>; <LINK REF="REF-Restrepo-2011" TYPE="REFERENCE">Restrepo 2011</LINK>; <LINK REF="REF-Cavenaghi-2011" TYPE="REFERENCE">Cavenaghi 2011</LINK>; <LINK REF="STD-Ferreira-2010" TYPE="STUDY">Ferreira 2010</LINK>, <LINK REF="STD-Renault-2009" TYPE="STUDY">Renault 2009</LINK>; <LINK REF="STD-Haeffener-2008" TYPE="STUDY">Haeffener 2008</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="REF-Hall-1991" TYPE="REFERENCE">Hall 1991</LINK>; <LINK REF="REF-Hall-1996" TYPE="REFERENCE">Hall 1996</LINK>; <LINK REF="REF-Kips-1997" TYPE="REFERENCE">Kips 1997</LINK>; <LINK REF="REF-Mang-1991" TYPE="REFERENCE">Mang 1991</LINK>; <LINK REF="REF-Marini-1984" TYPE="REFERENCE">Marini 1984</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="REF-Weiner-1997" TYPE="REFERENCE">Weiner 1997</LINK>).</P>
<P>This updated systematic review has included data from seven trials investigating the prevention of pulmonary complications using IS after CABG.</P>
<P>The past five published systematic reviews and guidelines ( <LINK REF="REF-Restrepo-2011" TYPE="REFERENCE">Restrepo 2011</LINK>; <LINK REF="REF-Brooks-2001" TYPE="REFERENCE">Brooks 2001</LINK>; <LINK REF="REF-Overend-2001" TYPE="REFERENCE">Overend 2001</LINK>; <LINK REF="REF-Pasquina-2003" TYPE="REFERENCE">Pasquina 2003</LINK>; <LINK REF="REF-Thomas-1994" TYPE="REFERENCE">Thomas 1994</LINK>) have analysed respiratory physiotherapy for the prevention of pulmonary complications after different operations, but they obtained conflicting results. The benefits of such techniques remained uncertain as data came from different operations and the pooled data came from different end points, such as pulmonary infiltrates, consolidation or atelectasis. Commentators have noted the lack of evidence of efficacy of IS in some studies (<LINK REF="REF-Restrepo-2011" TYPE="REFERENCE">Restrepo 2011</LINK>; <LINK REF="REF-Pasquina-2003" TYPE="REFERENCE">Pasquina 2003</LINK>; <LINK REF="REF-Freitas-2007" TYPE="REFERENCE">Freitas 2007</LINK>; <LINK REF="REF-Celli-1984" TYPE="REFERENCE">Celli 1984</LINK>; <LINK REF="REF-Craven-1974" TYPE="REFERENCE">Craven 1974</LINK>; <LINK REF="REF-Hall-1996" TYPE="REFERENCE">Hall 1996</LINK>), but others claim that its effectiveness depends on the selection of patients, careful instruction, and supervision of patients during respiratory training (<LINK REF="REF-Weindler-2001" TYPE="REFERENCE">Weindler 2001</LINK>).</P>
<P>Previous systematic reviews performed by us concluded that there was no evidence of benefit from IS in reducing pulmonary complications and in decreasing the negative effects on pulmonary function in patients undergoing CAGB (<LINK REF="REF-Freitas-2007" TYPE="REFERENCE">Freitas 2007</LINK>).</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>Due to the lack of sufficient quality evidence, we still cannot make definitive statements about the effectiveness of IS for the prevention of pulmonary complications after CABG. Most studies were small and did not detect significant differences between groups. In addition, due to the the variability of comparisons it was difficult to pool studies for analysis. In the seven trials included, five different regimens of therapy were tested against IS. This made the pooling of data of dubious value and we did not attempt to do this. The variation in usual practice may be due to the lack of a 'gold standard' method for respiratory physiotherapy (<LINK REF="REF-Tramer-1998" TYPE="REFERENCE">Tramer 1998</LINK>). The best comparison would be to use a placebo or no intervention along with the total absence of physiotherapy as control (<LINK REF="REF-Temple-2000" TYPE="REFERENCE">Temple 2000</LINK>). However this is usually considered unethical. In this review only two trials (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>) used a virtually no treatment control group. These trials, patients in the control group were seen before the operation by a physiotherapist, who explained the need to move about after surgery and to expectorate excess bronchial secretions, and taught early mobilization with active exercises of the upper and lower limbs, forced expirations with the glottis open (huffing) and coughing with sternal support.</P>
<P>
<B>Potencial biases in the review process</B>
</P>
<P>This updated review was limited by the low quality of the trials available for inclusion. The methodological descriptions reported inadequate methods of randomisation and concealment of allocation, and there were limitations to blinding.</P>
<P>There were no differences among the three treatment programs in improving lung volumes or preventing postoperative pulmonary complications. This is one of the few studies to include a control group in the research design. Thus the efficacy of IS when compared with the absence of intervention can be based only on these two small trials (<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>).</P>
<P>The IS treatment regimes used in the included studies were different, ranging from five breaths repeated every 2 hours to 10 breaths repeated every hour. Two trials (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>) postulated that insufficient self-administration of IS might be a possible explanation for the failure of the treatment. This inconsistency suggests uncertainty about the optimal treatment regime for IS.</P>
<P>The high variability in the rate of events was another limitation. For instance, the average incidence of pneumonia was 0-12% (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>) and atelectasis was 4-80% (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>; <LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>). Variability may be explained by the absence of a uniform definition of pneumonia and atelectasis in the primary studies and the limited size of trials (only one study included groups of more than 50 patients; <LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>). In small trials, events may happen by random chance (<LINK REF="REF-Moore-1998" TYPE="REFERENCE">Moore 1998</LINK>). In the four trials included, the longest observation period was four days, this made it difficult to identify all pulmonary complications. Nosocomial pneumonia, for instance, occurs on average eight days after cardiac surgery (<LINK REF="REF-Leal_x002d_Noval-2000" TYPE="REFERENCE">Leal-Noval 2000</LINK>).</P>
<P>Additional respiratory physical therapy and/or mobilization and/or analgesia were used as adjunctive treatments in three of the included trials (<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>; <LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>; <LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>); however few treatments were described adequately. All these co-interventions, such as early mobilization (<LINK REF="REF-Chulay-1982" TYPE="REFERENCE">Chulay 1982</LINK>; <LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>; <LINK REF="REF-Scheidegger-1976" TYPE="REFERENCE">Scheidegger 1976</LINK>) and the intensity and method of postoperative analgesia, may have an impact on pulmonary function (<LINK REF="REF-Hedderich-1999" TYPE="REFERENCE">Hedderich 1999</LINK>). In large RCTs co-interventions are usually balanced between the groups, but, in small trials bias cannot be excluded.</P>
<P>No trial included in this systematic review evaluated the adverse effects of IS. However, Iverson et al (<LINK REF="STD-Iverson-1978" TYPE="STUDY">Iverson 1978</LINK>) reported that gastrointestinal complaints and nausea were rare in patients using IS, 2% and 0% respectively. This trial was excluded from this systematic review due to low methodological quality and inadequate allocation concealment.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-07-04 08:45:39 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-07-04 08:45:17 +0100" MODIFIED_BY="[Empty name]">
<P>For professionals and patients, the results of this review suggest that, in patients undergoing CABG when compared to treatment of physical therapy no evidence of benefit from IS compared with preoperative education or standard postsurgical physical therapy for preventing postoperative pulmonary complications, improving pulmonary function and oxygenation and/or reducing length of hospital stay. There is evidence that IS is better than IPPB in increasing respiratory muscle strength, however this may have some drawbacks compared with other positive airway pressure techniques. Our conclusions are based on a population of low surgical risk (excluded are people who took longer to wean off ventilators, people with pre-existing lung disease, people undergoing emergent CABG surgery, and people with postoperative cardiac neurological complications). The small number of studies, the modest numbers of patients, the methodological limitations and the adjunctive use of other treatments in these patients means that currently available trials of IS contribute little to making decisions on its use.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-07-04 08:45:39 +0100" MODIFIED_BY="[Empty name]">
<P>There is room for improvement in the methodological quality of studies aimed at evaluating the efficacy of IS. The methodological areas that can be improved are an adequate sample size, the concealment of allocation following the randomisation procedure, the use of a consensual definition of pulmonary complication and treatment regimes for use of IS.</P>
<P>A large scale RCT to asses the benefits of IS with and without standard postsurgical physical therapy compared with standard post-surgical physical therapy, and compared with the absence of physical therapy (preoperative education only) in patients undergoing CABG is needed. New RCTs should also follow Consort-Statement (www.consort-statement.org) guidelines and that would contribute to clinical decision-making in dentistry.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-06-02 22:04:00 +0100" MODIFIED_BY="[Empty name]">
<P>Trials Search Co-ordinator and Feedback Editor of Cochrane Heart Group, for searching databases.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-06-11 14:40:24 +0100" MODIFIED_BY="[Empty name]">
<P>
<I>Eliane Regina Ferreira Sernache de Freitas (ERFSF) and Alvaro Nagib Atallah (ANA) </I>proposed the protocol and guarantor of review. Jefferson Rosa Cardoso (JRC), Bernardo Garcia de Oliveira Soares (BGOS) and ERFSF assessed the titles and abstracts identified by the electronic search. ERFSF, JRC and ANA undertook the assessment of risk of bias. ERFSF and JRC extracted the information from the RCT. All authors corrected the last draft.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-08-08 11:23:07 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-07-04 08:53:34 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-07-04 08:52:59 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Crowe-1977" MODIFIED="2012-01-17 13:39:01 +0000" MODIFIED_BY="[Empty name]" NAME="Crowe 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Crowe JM, Brandlay CA</AU>
<TI>The effectiveness of incentive spirometry with physical therapy for high-risk patients after coronary artery bypass surgery</TI>
<SO>Physical Therapy</SO>
<YR>1977</YR>
<VL>77</VL>
<NO>3</NO>
<PG>260-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dull-1983" MODIFIED="2010-12-23 18:09:12 +0000" MODIFIED_BY="[Empty name]" NAME="Dull 1983" YEAR="1983">
<REFERENCE MODIFIED="2010-12-23 18:09:12 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dull JL, Dull WL</AU>
<TI>Are maximal inspiratory breathing exercises or incentive spirometry better than early mobilization after cardiopulmonary bypass?</TI>
<SO>Physical Therapy</SO>
<YR>1983</YR>
<VL>63</VL>
<NO>5</NO>
<PG>655-659</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-12-23 18:07:10 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1989" MODIFIED="2011-12-26 18:17:37 +0000" MODIFIED_BY="[Empty name]" NAME="Jenkins 1989" YEAR="1989">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins SC, Soutar SA, Loukota JM, Johnson LC, Moxham J</AU>
<TI>Physiotherapy after coronary artery surgery: are breathing exercises necessary?</TI>
<SO>Thorax</SO>
<YR>1989</YR>
<VL>44</VL>
<NO>8</NO>
<PG>634-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matte-2000" NAME="Matte 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Matte P, Jacquet L, Van Dyck V, Goenen M</AU>
<TI>Effects of conventional physiotherapy, continuous positive airway pressure and non-invasive ventilatory support with bilevel positive airway pressure after coronary artery bypass grafting</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2000</YR>
<VL>44</VL>
<NO>1</NO>
<PG>75-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oikkonen-1991" NAME="Oikkonen 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oikkonen M, Karjalainen K, Kahara V, Kuosa R, Schavikin L</AU>
<TI>Comparison of incentive spirometry and intermittent positive pressure breathing after coronary artery bypass graft</TI>
<SO>Chest</SO>
<YR>1991</YR>
<VL>99</VL>
<NO>1</NO>
<PG>60-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Romanini-2007" MODIFIED="2012-07-04 08:51:30 +0100" MODIFIED_BY="[Empty name]" NAME="Romanini 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-07-04 08:51:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Romanini W, Muller AP, Carvalho KAT, Olandoski M, Faria-Neto JR, Mendes FL,et al</AU>
<TI>The effects of intermittent positive pressure and incentive spirometry in the postoperative of myocardial revascularizarion</TI>
<TO>Os efeitos da pressão positiva intermitente e do incentivador respiratório no pós-operatório de revascularização miocárdica</TO>
<SO>Arq Bras Cardiol</SO>
<YR>2007</YR>
<VL>89</VL>
<NO>2</NO>
<PG>105 - 110</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Savci-2006" MODIFIED="2012-07-04 08:52:59 +0100" MODIFIED_BY="[Empty name]" NAME="Savci 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-07-04 08:51:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Savci S Sakinç S, Ince DI, Arikan H, Zehr C, Buran Y, Kuralay E</AU>
<TI>Active cycle of breathing techniques and incentive spirometer in coronary artery bypass graft surgery</TI>
<SO>Fizyoterapi Rehabilitasyon</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>2</NO>
<PG>61 - 69</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-07-04 08:52:59 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-07-04 08:53:34 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ferreira-2010" MODIFIED="2012-07-04 08:53:18 +0100" MODIFIED_BY="[Empty name]" NAME="Ferreira 2010" YEAR="2010">
<REFERENCE MODIFIED="2011-07-16 23:48:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ferreira GM, Haeffner MP, Barreto SSM, Dall' Ago</AU>
<TI>Incentive spirometry with expiratory positive airway pressure brings benefits after myocardial revascularization</TI>
<SO>Arquivos Brasileiros de Cardiologia</SO>
<YR>2010</YR>
<VL>94</VL>
<NO>2</NO>
<PG>230-235</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-07-04 08:53:18 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gale-1980" NAME="Gale 1980" YEAR="1980">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gale GD, Sanders DE</AU>
<TI>Incentive spirometry: its value after cardiac surgery</TI>
<SO>Canadian Anaesthetists' Society Journal</SO>
<YR>1980</YR>
<VL>27</VL>
<NO>5</NO>
<PG>475-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haeffener-2008" MODIFIED="2012-07-04 08:53:34 +0100" MODIFIED_BY="[Empty name]" NAME="Haeffener 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-07-04 08:52:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haeffener MP, Ferreira GM, Barreto SSM, Arena R, DallÁgo P.</AU>
<TI>Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications, improves pulmonary function and 6-minute walk distance in patients undergoing coronary artery bypass graft surgery</TI>
<SO>American Heart Journal</SO>
<YR>2008</YR>
<VL>156</VL>
<NO>5</NO>
<PG>900.e2 - 900.e7</PG>
<IDENTIFIERS MODIFIED="2010-12-08 18:34:44 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-12-08 18:34:44 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="101016"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-07-04 08:53:34 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iverson-1978" NAME="Iverson 1978" YEAR="1978">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iverson LIG, Ecker RR, Fox HE, May IA</AU>
<TI>A comparative study of IPPB, the incentive spirometer, and blow bottles: the prevention of atelectasis following cardiac surgery</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>1978</YR>
<VL>25</VL>
<NO>3</NO>
<PG>197-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1990" MODIFIED="2010-01-12 19:45:18 +0000" MODIFIED_BY="[Empty name]" NAME="Jenkins 1990" YEAR="1990">
<REFERENCE MODIFIED="2010-01-12 19:45:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins SC, Soutar SA, Loukota JM, Johnson LC, Moxham J</AU>
<TI>A comparison of breathing exercises, incentive spirometry and mobilisation after coronary artery</TI>
<SO>Physiotherapy Theory and Practice</SO>
<YR>1990</YR>
<VL>6</VL>
<NO>3</NO>
<PG>117-126</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mahler-1998" NAME="Mahler 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mahler HI, Kulik JA</AU>
<TI>Effects of preparatory videotapes on self-efficacy beliefs and recovery from coronary bypass surgery</TI>
<SO>Annals of Behavioral Medicine</SO>
<YR>1998</YR>
<VL>20</VL>
<NO>1</NO>
<PG>39-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oulton-1981" NAME="Oulton 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oulton JL, Hobbs GM, Hicken P</AU>
<TI>Incentive breathing devices and chest physiotherapy: a controlled therapy</TI>
<SO>Canadian Journal of Surgery</SO>
<YR>1981</YR>
<VL>24</VL>
<NO>6</NO>
<PG>638-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paul-1981" NAME="Paul 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paul WL, Dows JB</AU>
<TI>Postoperative atelectasis. Intermittent positive pressure breathing, incentive spirometry and face-mask positive and-expiratory pressure</TI>
<SO>Archives of Surgery</SO>
<YR>1981</YR>
<VL>116</VL>
<NO>7</NO>
<PG>861-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rau-1988" NAME="Rau 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rau JL Jr, Thomas L, Haynes RL</AU>
<TI>The effect of method of administering incentive spirometry on postoperative pulmonary complications in coronary artery bypass patients</TI>
<SO>Respiratory Care</SO>
<YR>1988</YR>
<VL>33</VL>
<NO>9</NO>
<PG>771-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Renault-2009" MODIFIED="2011-12-27 03:53:50 +0000" MODIFIED_BY="[Empty name]" NAME="Renault 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-12-27 03:53:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Renault JA, Costa-Val R, Rosseti MB, Houri Neto M</AU>
<TI>Comparison between deep breathing exercises and incentive spirometry after CABG surgery</TI>
<SO>Revista Brasileira de Cirurgia Cardiovascular</SO>
<YR>2009</YR>
<VL>24</VL>
<NO>2</NO>
<PG>165-172</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-12-07 21:48:13 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-12-07 21:48:13 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stock-1984" NAME="Stock 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stock MC, Dows JB, Cooper RB, Lebenson IM, Cleveland J, Weaver DE, et al</AU>
<TI>Comparison of continuous positive airway pressure, incentive spirometry, and conservative therapy after cardiac operations</TI>
<SO>Critical Care Medicine</SO>
<YR>1984</YR>
<VL>12</VL>
<NO>11</NO>
<PG>969-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vraciu-1977" NAME="Vraciu 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vraciu JK, Vraciu RA</AU>
<TI>Effectiveness of breathing exercises in preventing pulmonary complications following open heart surgery</TI>
<SO>Physical Therapy</SO>
<YR>1977</YR>
<VL>57</VL>
<NO>12</NO>
<PG>1367-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-08-08 11:23:07 +0100" MODIFIED_BY="Manwai Lam">
<ADDITIONAL_REFERENCES MODIFIED="2012-08-08 11:23:07 +0100" MODIFIED_BY="Manwai Lam">
<REFERENCE ID="REF-AARC-1991" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="AARC 1991" TYPE="JOURNAL_ARTICLE">
<AU>Hilling L, Bakow E, Fink J, Kelly C, Sobush D, Southorn PA</AU>
<TI>AARC (American Association for Respiratory Care) clinical practice guideline. Incentive spirometry</TI>
<SO>Respiratory Care</SO>
<YR>1991</YR>
<VL>36</VL>
<NO>12</NO>
<PG>1402-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ACC_x002f_AHA-1999" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="ACC/AHA 1999" TYPE="JOURNAL_ARTICLE">
<AU>Eagle KA, Guyton RA, Davidiff R, Ewy GA, Fonger J, Gardner TJ, et al</AU>
<TI>ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)</TI>
<SO>Journal of the American College of Cardiology</SO>
<YR>1999</YR>
<VL>34</VL>
<NO>4</NO>
<PG>1262-347</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Agostini-2008" MODIFIED="2011-12-27 01:14:40 +0000" MODIFIED_BY="[Empty name]" NAME="Agostini 2008" TYPE="JOURNAL_ARTICLE">
<AU>Agostini P, Calvert R, Subramanian H, Naidu B</AU>
<TI> Is incentive spirometry effective following thoracic surgery?</TI>
<SO>Interactive Cardiovascular and Thoracic Surgery</SO>
<YR>2008</YR>
<VL>7</VL>
<NO>2</NO>
<PG>297-300</PG>
<IDENTIFIERS MODIFIED="2011-12-27 01:14:40 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-27 01:14:40 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1510/icvts.2007.171025"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-ATS-2002" MODIFIED="2012-04-21 22:07:01 +0100" MODIFIED_BY="[Empty name]" NAME="ATS 2002" TYPE="JOURNAL_ARTICLE">
<AU>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories American Thoracic Society</AU>
<TI>ATS statement: guidelines for the six-minute walk test</TI>
<SO>Am j Respir Crit Care Med</SO>
<YR>2002</YR>
<VL>166</VL>
<PG>111-117</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bartlett-1970" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Bartlett 1970" TYPE="JOURNAL_ARTICLE">
<AU>Bartlett RH, Krop P, Hanson EL, Moore FD</AU>
<TI>Physiology of yawning and its application to postoperative care</TI>
<SO>Surgical Forum</SO>
<YR>1970</YR>
<VL>21</VL>
<PG>223-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bartlett-1973" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Bartlett 1973" TYPE="JOURNAL_ARTICLE">
<AU>Bartlett RH, Gazzaniga AB, Geraghty TR</AU>
<TI>Respiratory maneuvers to prevent postoperative pulmonary complications. A critical review</TI>
<SO>JAMA</SO>
<YR>1973</YR>
<VL>224</VL>
<PG>1017-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Berrizbetia-1989" MODIFIED="2011-12-26 23:11:26 +0000" MODIFIED_BY="[Empty name]" NAME="Berrizbetia 1989" TYPE="JOURNAL_ARTICLE">
<AU>Berrizbeitia LD, Tessler S, Jacobowitz IJ, Kaplan P, Budzilowicz L, Cunningham JN</AU>
<TI>Effect of sternotomy and coronary bypass surgery on postoperative pulmonary mechanics. Comparison of internal mammary and saphenous vein bypass grafts</TI>
<SO>Chest</SO>
<YR>1989</YR>
<VL>96</VL>
<NO>4</NO>
<PG>873-876</PG>
<IDENTIFIERS MODIFIED="2011-12-26 23:10:47 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-26 23:10:47 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1378/chest.96.4.873"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Brooks-2001" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Brooks 2001" TYPE="JOURNAL_ARTICLE">
<AU>Brooks D, Crowe J, Kelsey CJ, Lacy JB, Parsons J, Solway S</AU>
<TI>A clinical practice guideline on peri-operative cardiorespiratory physical therapy</TI>
<SO>Physiotherapy Canada</SO>
<YR>2001</YR>
<VL>53</VL>
<NO>1</NO>
<PG>9-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cavenaghi-2011" MODIFIED="2011-12-27 00:30:12 +0000" MODIFIED_BY="[Empty name]" NAME="Cavenaghi 2011" TYPE="JOURNAL_ARTICLE">
<AU>Cavenaghi S, Ferreira LL, Marino LH, Lamari NM</AU>
<TI>Respiratory physiotherapy in the pre and postoperative myocardial revascularization surgery</TI>
<SO>Revista Brasileira de Cirurgia Cardiovascular</SO>
<YR>2011</YR>
<VL>26</VL>
<NO>3</NO>
<PG>455-461</PG>
<IDENTIFIERS MODIFIED="2011-12-26 15:42:20 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-26 15:40:51 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.5935/1678-9741.20110022"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Celli-1984" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Celli 1984" TYPE="JOURNAL_ARTICLE">
<AU>Celli BR, Rodriguez KS, Snider GL</AU>
<TI>A controlled trial of intermittent positive pressure breathing, incentive spirometry, and deep breathing exercises in preventing pulmonary complications after abdominal surgery</TI>
<SO>American Review of Respiratory Disease</SO>
<YR>1984</YR>
<VL>130</VL>
<NO>1</NO>
<PG>12-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chandler-1984" MODIFIED="2012-04-21 21:54:50 +0100" MODIFIED_BY="[Empty name]" NAME="Chandler 1984" TYPE="JOURNAL_ARTICLE">
<AU>Chandler KW, Rozas CJ, Kory RC, Goldman AL</AU>
<TI>Bilateral diaphragmatic paralysis complicating local cardiac hypothermia during open heart surgery</TI>
<SO>Am J Med</SO>
<YR>1984</YR>
<VL>77</VL>
<NO>2</NO>
<PG>243-249</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chulay-1982" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Chulay 1982" TYPE="JOURNAL_ARTICLE">
<AU>Chulay M, Brown J, Summer W</AU>
<TI>Effect of postoperative immobilization after coronary artery bypass surgery</TI>
<SO>Critical Care Medicine</SO>
<YR>1982</YR>
<VL>10</VL>
<NO>3</NO>
<PG>176-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chuter-1990" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Chuter 1990" TYPE="JOURNAL_ARTICLE">
<AU>Chuter TM, Weissman C, Mathews DM, Starker PM</AU>
<TI>Diaphragmatic breathing maneuvers and movement of the diaphragm after cholecystectomy</TI>
<SO>Chest</SO>
<YR>1990</YR>
<VL>97</VL>
<NO>5</NO>
<PG>1110-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clarke-2001" MODIFIED="2012-06-13 04:05:28 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Clarke 2001" TYPE="BOOK">
<AU>Clarke M, Oxman AD</AU>
<TI>Cochrane Reviewers' Handbook 4.1.1</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clarke-2003" MODIFIED="2012-06-13 04:06:24 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Clarke 2003" TYPE="BOOK">
<AU>Clarke M, Oxman AD, editors</AU>
<TI>Section 6: Assessment of study quality</TI>
<SO>Cochrane Reviewers' Handbook 4.1.6 [updated January 2003 ]</SO>
<YR>2003</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2012-06-13 03:56:04 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-CPA-1990" MODIFIED="2012-06-13 03:10:26 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="CPA 1990" TYPE="CORRESPONDENCE">
<AU>Canadian Physiotherapy Association (CPA)</AU>
<TI>Final Consensus Statement</TI>
<SO>Contact</SO>
<YR>1990 (April)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Craven-1974" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Craven 1974" TYPE="JOURNAL_ARTICLE">
<AU>Craven JL, Evans GA, Davenport PJ, Williams RHP</AU>
<TI>The evaluation of incentive spirometry in the management of postoperative pulmonary complications</TI>
<SO>British Journal of Surgery</SO>
<YR>1974</YR>
<VL>61</VL>
<NO>10</NO>
<PG>793-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Daganou-1998" MODIFIED="2012-07-02 14:03:44 +0100" MODIFIED_BY="Manwai Lam" NAME="Daganou 1998" TYPE="JOURNAL_ARTICLE">
<AU>Daganou M, Dimopoulou I, Michalopoulos N, Papadopoulos K, Karakatsani A, Geroulanos S,et al</AU>
<TI>Respiratory complications after coronary artery bypass surgery with unilateral or bilateral internal mammary artery grafting</TI>
<SO>Chest</SO>
<YR>1998</YR>
<VL>113</VL>
<NO>5</NO>
<PG>1285-1289</PG>
<IDENTIFIERS MODIFIED="2011-12-26 23:04:16 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-26 23:04:16 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1378/chest.113.5.1285"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ferguson-1999" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Ferguson 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ferguson MK</AU>
<TI>Preoperative assessment of pulmonary risk</TI>
<SO>Chest</SO>
<YR>1999</YR>
<VL>115</VL>
<NO>5 Suppl</NO>
<PG>58S-63S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Follmann-1992" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Follmann 1992" TYPE="JOURNAL_ARTICLE">
<AU>Follmann D, Elliot P, Suh I, Cuter J</AU>
<TI>Variance imputation for overviews of clinical trials with continuous response</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1992</YR>
<VL>45</VL>
<NO>7</NO>
<PG>769-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freitas-2007" MODIFIED="2012-08-08 11:23:07 +0100" MODIFIED_BY="[Empty name]" NAME="Freitas 2007" TYPE="COCHRANE_REVIEW">
<AU>Freitas ERFS, Soares BGO, CArdoso JR, Atallh AN</AU>
<TI>Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2012-08-08 11:23:07 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-08-08 11:23:07 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004466.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Groeneveld-2006" MODIFIED="2012-07-02 14:05:09 +0100" MODIFIED_BY="Manwai Lam" NAME="Groeneveld 2006" TYPE="JOURNAL_ARTICLE">
<AU>Groeneveld AB, Verheij J, van den Berg FG, Wisselink W, Rauwerda JA</AU>
<TI>Increased pulmonary capillary permeability and extravascular lung water after major vascular surgery: effect on radiography and ventilatory variables</TI>
<SO>European journal of anaesthesiology</SO>
<YR>2006</YR>
<VL>23</VL>
<NO>1</NO>
<PG>36-41</PG>
<IDENTIFIERS MODIFIED="2011-12-26 22:55:28 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Groeneveld-2007" MODIFIED="2011-12-26 23:06:59 +0000" MODIFIED_BY="[Empty name]" NAME="Groeneveld 2007" TYPE="JOURNAL_ARTICLE">
<AU>Groeneveld AB, Jansen EK, Verheij J</AU>
<TI>Mechanisms of pulmonary dysfunction after on-pump and off-pump cardiac surgery: a prospective cohort study</TI>
<SO>Journal of cardiothoracic surgery</SO>
<YR>2007</YR>
<VL>2</VL>
<NO>11</NO>
<PG>1-7</PG>
<IDENTIFIERS MODIFIED="2011-12-26 23:00:36 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-26 23:00:36 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1749-8090-2-11"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hall-1991" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Hall 1991" TYPE="JOURNAL_ARTICLE">
<AU>Hall JL, Tarala R, Harris J, Tapper J, Christiansen K</AU>
<TI>Incentive spirometry versus routine chest physiotherapy for prevention of pulmonary complications after abdominal surgery</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>337</VL>
<NO>8747</NO>
<PG>953-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hall-1996" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Hall 1996" TYPE="JOURNAL_ARTICLE">
<AU>Hall JC, Tarala RA, Tapper J, Hall JL</AU>
<TI>Prevention of respiratory complications after abdominal surgery: A randomised clinical trial</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>312</VL>
<NO>7024</NO>
<PG>148-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hallbook-1984" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Hallbook 1984" TYPE="JOURNAL_ARTICLE">
<AU>Hallbook T, Lindblad B, Lindroth B, Wolff T</AU>
<TI>Prophylaxis against pulmonary complications in patients undergoing gall-bladder surgery. A comparison between early mobilization, physiotherapy with and without bronchodilatation</TI>
<SO>Annales Chirurgiae et Gynaecologiae</SO>
<YR>1984</YR>
<VL>73</VL>
<NO>2</NO>
<PG>55-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hedderich-1999" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Hedderich 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hedderich R, Ness TJ</AU>
<TI>Analgesia for trauma and burns</TI>
<SO>Critical Care Clinics</SO>
<YR>1999</YR>
<VL>15</VL>
<NO>1</NO>
<PG>167-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-1988" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Higgins 1988" TYPE="JOURNAL_ARTICLE">
<AU>Higgins M, Kannel WB, Garrison R, Pinski J, Stokes J 3rd</AU>
<TI>Hazards of obesity. The Framingham experience</TI>
<SO>Acta Medica Scandinavica - Supplementum</SO>
<YR>1988</YR>
<VL>723</VL>
<PG>23-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-07-02 14:05:30 +0100" MODIFIED_BY="Manwai Lam" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins J, Green S</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions</TI>
<SO>Wiley-Blackwell</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hulzebos-2003" MODIFIED="2012-07-02 14:05:43 +0100" MODIFIED_BY="Manwai Lam" NAME="Hulzebos 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hulzebos EH, Van Meeteren NL, De Bie RA, Dagnelie PC, Helders PJ</AU>
<TI>Prediction of postoperative pulmonary complications on the basis of preoperative risk factors in patients who had undergone coronary artery bypass graft surgery</TI>
<SO>Physical therapy</SO>
<YR>2011</YR>
<VL>113</VL>
<NO>5</NO>
<PG>994-1002</PG>
<IDENTIFIERS MODIFIED="2011-12-27 00:15:15 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-27 00:15:15 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1213/ANE.0b013e31822c94a8"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jenkins-1986" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Jenkins 1986" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins SC, Soutar SA</AU>
<TI>A survey into the use of incentive spirometry following coronary artery by-pass graft surgery</TI>
<SO>Physiotherapy</SO>
<YR>1986</YR>
<VL>72</VL>
<NO>10</NO>
<PG>492-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kannel-1980" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Kannel 1980" TYPE="JOURNAL_ARTICLE">
<AU>Kannel WB, Dawber JR, Mc Gee DL</AU>
<TI>Perspectives on systolic hypertension. The Framingham study</TI>
<SO>Circulation</SO>
<YR>1980</YR>
<VL>61</VL>
<NO>6</NO>
<PG>1179-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kannel-1984" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Kannel 1984" TYPE="JOURNAL_ARTICLE">
<AU>Kannel WB, McGee DL, Castelli WP</AU>
<TI>Latest perspectives on cigarette smoking and cardiovascular disease: The Framingham study</TI>
<SO>Journal of Cardiac Rehabilitation</SO>
<YR>1984</YR>
<VL>4</VL>
<NO>7</NO>
<PG>267-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kannel-1985" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Kannel 1985" TYPE="JOURNAL_ARTICLE">
<AU>Kannel WB, Wilson PWF, Blair SN</AU>
<TI>Epidemiologic assessment of the role of physical activity and fitness in development of cardiovascular disease</TI>
<SO>American Heart Journal</SO>
<YR>1985</YR>
<VL>109</VL>
<NO>4</NO>
<PG>876-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kannel-1986" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Kannel 1986" TYPE="JOURNAL_ARTICLE">
<AU>Kannel WB</AU>
<TI>Hypertension: Relationship with other risk factors</TI>
<SO>Drugs</SO>
<YR>1986</YR>
<VL>31</VL>
<NO>Suppl 1</NO>
<PG>1-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kannel-1987" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Kannel 1987" TYPE="JOURNAL_ARTICLE">
<AU>Kannel WB, Sytkowski PA</AU>
<TI>Atherosclerosis risk factors</TI>
<SO>Pharmacology &amp; Therapeutics</SO>
<YR>1987</YR>
<VL>32</VL>
<NO>3</NO>
<PG>207-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keenan-2005" MODIFIED="2011-12-26 22:31:29 +0000" MODIFIED_BY="[Empty name]" NAME="Keenan 2005" TYPE="JOURNAL_ARTICLE">
<AU>Keenan TD, Abu-Omar Y, Taggart DP</AU>
<TI>Bypassing the pump: changing practices in coronary artery surgery.</TI>
<SO>Chest</SO>
<YR>2005</YR>
<VL>128</VL>
<NO>1</NO>
<PG>363-369</PG>
<IDENTIFIERS MODIFIED="2011-12-26 22:31:29 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-26 22:31:29 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1378/chest.128.1.363"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kips-1997" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Kips 1997" TYPE="JOURNAL_ARTICLE">
<AU>Kips JC</AU>
<TI>Preoperative pulmonary evaluation</TI>
<SO>Acta Clinica Belgica</SO>
<YR>1997</YR>
<VL>52</VL>
<NO>5</NO>
<PG>301-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lawrence-1995" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Lawrence 1995" TYPE="JOURNAL_ARTICLE">
<AU>Lawrence VA, Hilsenbeck SG, Mulrow CD, Dhanbla R, Sapp J, Page CP</AU>
<TI>Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>1995</YR>
<VL>10</VL>
<NO>12</NO>
<PG>671-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leal_x002d_Noval-2000" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Leal-Noval 2000" TYPE="JOURNAL_ARTICLE">
<AU>Leal-Noval SR, Marquez-Vacaro JA, Garcia-Curiel A, Camacho-Larana P, Rincon-Ferrari MD, Ordonez-Fernandez A, et al</AU>
<TI>Nosocomial pneumonia in patients undergoing heart surgery</TI>
<SO>Critical Care Medicine</SO>
<YR>2000</YR>
<VL>28</VL>
<NO>4</NO>
<PG>935-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2012-01-17 13:14:41 +0000" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies.</TI>
<SO>In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011).</SO>
<YR>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mang-1991" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Mang 1991" TYPE="JOURNAL_ARTICLE">
<AU>Mang H, Kacmarek RM</AU>
<TI>Prevention of pulmonary complications after abdominal surgery</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>228</VL>
<NO>8762</NO>
<PG>312-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marini-1984" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Marini 1984" TYPE="JOURNAL_ARTICLE">
<AU>Marini JJ</AU>
<TI>Postoperative atelectasis: pathophysiology, clinical importance, and principles of management</TI>
<SO>Respiratory Care</SO>
<YR>1984</YR>
<VL>29</VL>
<NO>5</NO>
<PG>516-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Meyers-1975" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Meyers 1975" TYPE="JOURNAL_ARTICLE">
<AU>Meyers JR, Lembeck L, O'Kane H, Baue AE</AU>
<TI>Changes in functional residual capacity of the lung after operation</TI>
<SO>Archives of Surgery</SO>
<YR>1975</YR>
<VL>110</VL>
<NO>5</NO>
<PG>567-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1999" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Moher 1999" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF</AU>
<TI>Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<NO>9193</NO>
<PG>1896-900</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mohr-1996" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Mohr 1996" TYPE="JOURNAL_ARTICLE">
<AU>Mohr DN, Lavender RC</AU>
<TI>Preoperative pulmonary evaluation. Identifying patients at increased risk for complications</TI>
<SO>Postgraduate Medicine</SO>
<YR>1996</YR>
<VL>100</VL>
<NO>5</NO>
<PG>241-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mohr-2011" MODIFIED="2012-07-02 14:07:04 +0100" MODIFIED_BY="Manwai Lam" NAME="Mohr 2011" TYPE="JOURNAL_ARTICLE">
<AU> Mohr FW, Rastan AJ, Serruys PW, Kappetein AP, Holmes DR, Pomar JL, et al</AU>
<TI>Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years.</TI>
<SO>The Journal of thoracic and cardiovascular surgery</SO>
<YR>2011</YR>
<VL>141</VL>
<NO>1</NO>
<PG>130-140</PG>
<IDENTIFIERS MODIFIED="2011-12-26 22:19:00 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-26 22:19:00 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.jtcvs.2010.07.094"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moore-1998" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Moore 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ</AU>
<TI>Size is everything - large amounts of information are need to overcome random effects in estimating direction and magnitude of treatment effects</TI>
<SO>Pain</SO>
<YR>1998</YR>
<VL>78</VL>
<NO>3</NO>
<PG>209-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mortasawi-2004" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Mortasawi 2004" TYPE="JOURNAL_ARTICLE">
<AU>Mortasawi A, Arnrich B, Walter J, Frerichs I, Rosendahl U, Ennker J</AU>
<TI>Impact of age on the results of coronary artery bypass grafting</TI>
<SO>Asian Cardiovascular &amp; Thoracic Annals</SO>
<YR>2004</YR>
<VL>12</VL>
<NO>4</NO>
<PG>324-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Donohue-1985" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="O'Donohue 1985" TYPE="JOURNAL_ARTICLE">
<AU>O' Donohue WJ Jr</AU>
<TI>National survey of the usage of lung expansion modalities for the prevention and treatment of post-operative atelectasis following abdominal and thoracic surgery</TI>
<SO>Chest</SO>
<YR>1985</YR>
<VL>87</VL>
<NO>1</NO>
<PG>76-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Overend-2001" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Overend 2001" TYPE="JOURNAL_ARTICLE">
<AU>Overend TJ, Anderson CM, Lucy SD, Bhatia C, Jonsson B, Timmermans C</AU>
<TI>The effect of incentive spirometry on postoperative pulmonary complications: a systematic review</TI>
<SO>Chest</SO>
<YR>2001</YR>
<VL>120</VL>
<NO>3</NO>
<PG>971-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pasquina-2003" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Pasquina 2003" TYPE="JOURNAL_ARTICLE">
<AU>Pasquina P, Tramers MR, Walder B</AU>
<TI>Prophylactic respiratory physiotherapy after cardiac surgery: systematic review</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7428</NO>
<PG>1379-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Petz-1979" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Petz 1979" TYPE="JOURNAL_ARTICLE">
<AU>Petz TJ</AU>
<TI>Physiologic effect of IPPB, blow bottles and motivates spirometry</TI>
<SO>Current Reviews in Respiratory Therapy</SO>
<YR>1979</YR>
<VL>1</VL>
<PG>107-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pinheiro-2011" MODIFIED="2012-07-02 14:07:34 +0100" MODIFIED_BY="Manwai Lam" NAME="Pinheiro 2011" TYPE="JOURNAL_ARTICLE">
<AU>Pinheiro AC, Novais MCM, Gomes Neto M, Rodrigues MVH, Rodrigues Junior ES, Aras-Junior R, et al</AU>
<TI>Estimation of lung vital capacity before and after coronary artery bypass grafting surgery: a comparison of incentive spirometer and ventilometry</TI>
<SO>Journal of Cardiothoracic Surgery</SO>
<YR>2011</YR>
<VL>6</VL>
<NO>70</NO>
<PG>1-5</PG>
<IDENTIFIERS MODIFIED="2011-07-16 21:46:30 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-07-16 21:46:30 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1749-8090-6-70"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Renault-2008" MODIFIED="2012-04-21 21:46:39 +0100" MODIFIED_BY="[Empty name]" NAME="Renault 2008" TYPE="JOURNAL_ARTICLE">
<AU>Renault JA, Costa-Val Ricardo, Rosseti MB</AU>
<TI>Respiratory physiotherapy in the pulmonary dysfunction after cardiac surgery</TI>
<TO>Fisioterapia respiratoria na disfunção pulmonar pós-cirurgia cardiaca</TO>
<SO>Revista Brasileira de Cirurgia Cardiovascular</SO>
<YR>2008</YR>
<VL>23</VL>
<NO>4</NO>
<PG>562-569</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Restrepo-2011" MODIFIED="2011-12-26 15:47:52 +0000" MODIFIED_BY="[Empty name]" NAME="Restrepo 2011" TYPE="JOURNAL_ARTICLE">
<AU>Restrepo RD, Wettstein R, Wittnebel L, Tracy M</AU>
<TI>Incentive spirometry: 2011</TI>
<SO>Respiratory Care</SO>
<YR>2011</YR>
<VL>56</VL>
<NO>10</NO>
<PG>1600-1604</PG>
<IDENTIFIERS MODIFIED="2011-12-26 15:47:52 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-26 15:47:52 +0000" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE=" 22008401"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Scheidegger-1976" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Scheidegger 1976" TYPE="JOURNAL_ARTICLE">
<AU>Scheidegger D, Bentz L, Piolino C, Pusterla C, Gigon JP</AU>
<TI>Influence of early mobilisation of pulmonary function in surgical patients</TI>
<SO>European Journal of Intensive Care Medicine</SO>
<YR>1976</YR>
<VL>2</VL>
<NO>1</NO>
<PG>35-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Siafakas-1999" MODIFIED="2012-04-21 21:50:22 +0100" MODIFIED_BY="[Empty name]" NAME="Siafakas 1999" TYPE="JOURNAL_ARTICLE">
<AU>Siafakas NM, Mitrouska I, Bouros D, Georgopoulous D</AU>
<TI>Surgery and the respiratory muscle</TI>
<SO>Thorax</SO>
<YR>1999</YR>
<VL>54</VL>
<NO>5</NO>
<PG>458-465</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stiller-1994" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Stiller 1994" TYPE="JOURNAL_ARTICLE">
<AU>Stiller K, Montarello J, Wallace M, Daff M, Grant R, Jenkins S, et al</AU>
<TI>Efficacy of breathing and coughing exercises in the prevention of pulmonary complications after coronary artery surgery</TI>
<SO>Chest</SO>
<YR>1994</YR>
<VL>105</VL>
<NO>3</NO>
<PG>741-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Temple-2000" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Temple 2000" TYPE="JOURNAL_ARTICLE">
<AU>Temple R, Ellenberg SS</AU>
<TI>Placebo-controlled trials and active-control trials in the evaluation of new treatment. Part 1: Ethical and scientific issues</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2000</YR>
<VL>133</VL>
<NO>6</NO>
<PG>455-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thomas-1994" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Thomas 1994" TYPE="JOURNAL_ARTICLE">
<AU>Thomas JA, McIntosh JM</AU>
<TI>Are incentive spirometry, intermittent positive pressure breathing, and deep breathing exercises effective in the prevention of postoperative pulmonary complications after upper abdominal surgery? A systematic overview and meta-analysis</TI>
<SO>Physical Therapy</SO>
<YR>1994</YR>
<VL>74</VL>
<NO>1</NO>
<PG>3-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tramer-1998" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Tramer 1998" TYPE="JOURNAL_ARTICLE">
<AU>Tramer MR, Reynolds DJ, Moore RA, McQuay HJ</AU>
<TI>When placebo controlled trials are essential and equivalence trials are inadequate</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<NO>7162</NO>
<PG>875-880</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wattie-1998" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Wattie 1998" TYPE="JOURNAL_ARTICLE">
<AU>Wattie J</AU>
<TI>Incentive spirometry following coronary artery bypass surgery</TI>
<SO>Physiotherapy</SO>
<YR>1998</YR>
<VL>84</VL>
<NO>10</NO>
<PG>508-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weindler-2001" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Weindler 2001" TYPE="JOURNAL_ARTICLE">
<AU>Weindler J, Kiefer RT</AU>
<TI>The efficacy of postoperative incentive spirometry is influenced by the device-specific imposed work of breathing</TI>
<SO>Chest</SO>
<YR>2001</YR>
<VL>119</VL>
<NO>6</NO>
<PG>1858-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weiner-1997" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Weiner 1997" TYPE="JOURNAL_ARTICLE">
<AU>Weiner P, Man A, Weiner M, Rabner M, Waizman J, Magadle R, et al</AU>
<TI>The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection</TI>
<SO>Journal of Thoracic &amp; Cardiovascular Surgery</SO>
<YR>1997</YR>
<VL>113</VL>
<NO>3</NO>
<PG>552-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Weinstein-1987" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Weinstein 1987" TYPE="JOURNAL_ARTICLE">
<AU>Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L</AU>
<TI>Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model</TI>
<SO>American Journal of Public Health</SO>
<YR>1987</YR>
<VL>77</VL>
<NO>11</NO>
<PG>1417-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilking-1988" MODIFIED="2008-09-09 09:12:18 +0100" MODIFIED_BY="Karen Hovhannisyan" NAME="Wilking 1988" TYPE="JOURNAL_ARTICLE">
<AU>Wilking S, Belanger A, Kannel WB, D'Agostino RB, Steel K</AU>
<TI>Determinants of isolated systolic hypertension</TI>
<SO>JAMA</SO>
<YR>1988</YR>
<VL>260</VL>
<NO>23</NO>
<PG>3451-55</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2011-12-26 18:21:33 +0000" MODIFIED_BY="[Empty name]"/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-07-04 08:50:01 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-07-04 08:49:15 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-06-02 17:10:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Crowe-1977">
<CHAR_METHODS MODIFIED="2012-06-02 17:10:05 +0100" MODIFIED_BY="[Empty name]">
<P>Randomisation using a computer-generated random number table.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>185 patients with chronic airflow limitation (153 men) following CABG.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-22 23:51:45 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1 (n=95) were randomly assigned to postoperative physical therapy only. Group 2 (n = 90) were randomly assigned to postoperative physical therapy plus incentive spirometry. The incentive spirometry device was volume oriented.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary outcome measure: atelectasis, marked collapse or consolidation (estimated by chest X-ray). <BR/>Secondary outcome measures included: estimation of lung infection, oxygen saturation, and number of postoperative days in hospital.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Subjects receiving mammary artery conduits were equally distributed between the two treatment groups.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-04 08:46:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dull-1983">
<CHAR_METHODS MODIFIED="2010-12-23 19:09:07 +0000" MODIFIED_BY="[Empty name]">
<P>Method of randomisation unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-04 08:46:10 +0100" MODIFIED_BY="[Empty name]">
<P>49 consecutive patients scheduled for cardiopulmonary bypass surgery, specifically CABG or valve replacement.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-26 14:13:17 +0000" MODIFIED_BY="[Empty name]">
<P>Four hours after extubation, patients were randomly assigned to three groups. Group 1 (n =16) received early mobilization twice a day (ankle circumduction, range of motion to all extremities, three maximal coughs and encouragement and<I> assistance</I> to turn from side to side, sit up, or stand up); group 2 (n=16) received early mobilization plus maximal inspiratory breathing exercises (10 repetitions of maximal inhalation from residual volume) four times a day; group 3 (n=17) received early mobilization plus incentive spirometry (10 repetitions of maximal inhalations from residual volume with an incentive spirometer) four times a day.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-06-02 20:02:39 +0100" MODIFIED_BY="[Empty name]">
<P>Slow vital capacity, forced vital capacity; forced expiratory volume in one second, percentage of the forced vital capacity exhaled within the first second and forced slow between 200 and 1200 ml of forced vital capacity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-04 08:46:26 +0100" MODIFIED_BY="[Empty name]">
<P>The spirocare incentive breathing exercises were used.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-06-02 17:19:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-1989">
<CHAR_METHODS MODIFIED="2012-06-02 17:19:28 +0100" MODIFIED_BY="[Empty name]">
<P>Stratified randomisation for age.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>110 consecutive men undergoing CABG.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-01-11 17:47:34 +0000" MODIFIED_BY="[Empty name]">
<P>All patients were seen before surgery by a physiotherapist, who explained to need to move about after surgery and to expectorate excess bronchial secretions. Group 1 (n = 35) received usual postoperative physical therapy: three to five consecutive deep breaths were interspersed between a period of quite breathing, in the sitting or half lying position. Group 2 (n = 38) were taught to use an incentive spirometer (Triflo II, Sherwood Medical Industries) in the sitting or half lying position. Three to five consecutive breaths with the spirometer were interposed between period of quiet breathing. Group 3 (n = 37) received the preoperative physiotherapy advice only.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Vital capacity, functional residual capacity, and forced expiratory volume in 1 second (FEV1), at the bedside on the afternoon of the second postoperative day and at the same time each successive day.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Only white men were considered for inclusion in the study. Patients who had previously had cardiac surgery and those unable to walk the length of the ward (64 metres) for reasons other than angina were excluded.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-01-11 17:48:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Matte-2000">
<CHAR_METHODS MODIFIED="2010-01-11 17:47:47 +0000" MODIFIED_BY="[Empty name]">
<P>Method of randomisation unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>96 patients undergoing elective CABG with the use of mammary arteries.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>After extubation, patients were randomly assigned to three groups. Group 1 (n = 30) received routine chest physiotherapy (RCP: coughing exercises, aerosol therapy, mobilizations) plus incentive spirometry (Coach-volume) 20/2 h. Group 2 (n = 33) received RCP plus continuous positive airway pressure (CPAP), 5cm H2O, 1h/3h. Group 3 (n = 33) received RCP plus non invasive ventilation with two levels of pressure (NIV-2P), with expiratory positive airway pressure (EPAP) set at 5 cm H2O and peak inspiratory positive airway pressure (IPAP) at 12 cm H2O 1h/3h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-01-11 17:48:01 +0000" MODIFIED_BY="[Empty name]">
<P>Vital capacity and forced expiratory volume in 1 second were measured on the first postoperative day before the start of the study and on the second postoperative day (24 h after the start of the study). Chest X-rays obtained preoperatively and on the first and second postoperative day were analysed for atelectasis. Other measurements: arterial and mixed venous oxygen content, blood gases.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Patients with chronic obstructive pulmonary disease were excluded. Blood was drawn from the radial and the pulmonary artery for gas analysis.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-12-15 21:19:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Oikkonen-1991">
<CHAR_METHODS MODIFIED="2010-12-15 21:19:18 +0000" MODIFIED_BY="[Empty name]">
<P>Method of randomisation unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>52 patients (22 men) following CABG.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-12-15 21:19:31 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1 (n = 26) received incentive spirometry plus conventional postoperative physical therapy. The incentive spirometer (DHD Coach, DHD Medical Products, USA) was equipped with a volume-oriented goal indication and the aimed at inhalation exceeded 3 was repeated at least five times per session. Group 2 (n = 26) received intermittent positive pressure breathing (IPPB) (Bennett PR2, Puritan Bennett, USA) plus conventional postoperative physical therapy. The peak airway pressure was adjusted, ranging from 10 to 15 cm H2O at each session.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Vital capacity (expiratory), slow vital capacity, peak expiratory flow. Chest X-rays were analysed for atelectasis, pulmonary infiltration and pleural effusion. Arterial blood gas values were taken.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Patients with chronic obstructive pulmonary disease were excluded. Saphenous vein aorta coronary graft, and usually LIMA-LAD grafts were constructed under hypothermic bypass. Cold cardioplegia and local pericardial cooling were used.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-04 08:47:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Romanini-2007">
<CHAR_METHODS MODIFIED="2011-07-17 17:14:34 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized by drawing lots, prior to the surgery.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-17 16:43:29 +0100" MODIFIED_BY="[Empty name]">
<P>40 patients submitted to myocardial revascularization surgery. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-17 17:20:28 +0100" MODIFIED_BY="[Empty name]">
<P>The patients in the IPPB group (n=20 - 40% women and 60% men) were submitted to intermittent positive pressure breathing (IPPB) with a rubber facial mask for ten minutes, followed by a 5-minute interval and a new application for 10 minutes. </P>
<P>The IS group (n=20 - 20% women and 80% men) was submitted for the same time and interval.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-04 08:47:28 +0100" MODIFIED_BY="[Empty name]">
<P>The following postoperative parameters were assessed: oxygen saturation (SpO<SUB>2</SUB>) in ambient air measured by a pulse oxymeter manufactured by Nonin<SUP>®</SUP>, model 9500, current volume (CV = MV (minute volume)/RF (respiratory frequency), measured in a Whigth ventilometer manufactured by Respirameter<SUP>®</SUP>, model Ferraris-Mark 8, maximum inspiratory pressure (Ip<SUB>max </SUB>or MIP) and maximum expiratory pressure (Ep<SUB>max </SUB>or<SUB> </SUB>MEP), which was measured in a Gerar<SUP>®</SUP> equipment. These data were collected 24, 48 and 72 hours after surgery.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-17 17:00:03 +0100" MODIFIED_BY="[Empty name]">
<P>The volume-oriented incentive spirometry, using a Voldyne model 5000 <SUP>TM</SUP>, (Sherwood Medical, USA) and Müller Reanimator (MR) manufactured by Engesp<SUP>® </SUP>was used<SUP>.</SUP>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-07-17 20:00:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Savci-2006">
<CHAR_METHODS MODIFIED="2011-07-17 17:14:08 +0100" MODIFIED_BY="[Empty name]">
<P>Method of randomisation unclear</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-17 17:16:39 +0100" MODIFIED_BY="[Empty name]">
<P>Sixty male patients (41-75 years) with CABG.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-17 19:52:06 +0100" MODIFIED_BY="[Empty name]">
<P>All patients received basic post-operative respiratory physiotherapy including breathing exercises, instruction in huffing and coughing techniques, mobilization, and active exercises of upper limbs and thorax .The patients were instructed to sit out of bed and stand up on the first post-operative day (2-3 times). They walked 30 m in the intensive care unit in the morning and 80 m on the ward in the afternoon on the first post-operative. On the third post-operative day, they walked freely in the corridor. Active cycle breathing techniques (ACBT) consisted of 1-2 breathing control breaths, three thoracic expansion exercises followed by a 3 second breath hold at the end of deep inspiration, and the forced expiration techniques including 1-2 breathing control breaths combined with 1-2 huffs. Manual techniques were not included in ACBT. Siting or high sitting positions were used during the treatment. IS was applied as three deep breaths followed by a 3-second breath hold at the end of the deep inspirations. Afterward, 1-2 huffing was performed with 1-2 breathing control. On the first and the second post-operative days, treatment was applied twice a day, 1 minutes per session. From the third day following surgery, it was applied once a day for 15 minutes.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-17 20:00:14 +0100" MODIFIED_BY="[Empty name]">
<P>Vital capacity (VC), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), peak expiratory flow rate (PEF), functional capacity (six-minute walk test (6MWT)), pain intensity, partial oxygen pressure (PaO2), partial arterial carbon dioxide pressure (PaCO2), oxygen saturation (SaO2), bicarbonate level (HCO3), and arterial pH.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-17 17:19:25 +0100" MODIFIED_BY="[Empty name]">
<P>All patients had left internal mammaria artery graft </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-07-04 08:50:01 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2011-07-17 22:42:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ferreira-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-17 22:42:07 +0100" MODIFIED_BY="[Empty name]">
<P>Combined IS connected with EPAP </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gale-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Combined CABG with other interventions, and did not separate the results for CABG</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-17 22:42:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haeffener-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-17 22:42:21 +0100" MODIFIED_BY="[Empty name]">
<P>Combined IS connected with EPAP and showed the results in form of graphs or illustrations.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Iverson-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>Paper did not meet inclusion criteria. Allocation concealment inadequate.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-17 22:42:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-17 22:42:27 +0100" MODIFIED_BY="[Empty name]">
<P>Duplicated trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mahler-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Trial with non-relevant end-points.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Oulton-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Trial with non-relevant end-points.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Paul-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Paper did not meet inclusion criteria. Trial not controlled.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rau-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Trial with non-relevant end-points.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-04 08:50:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Renault-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-04 08:50:01 +0100" MODIFIED_BY="[Empty name]">
<P>Reported inconsistent data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Stock-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Combined CABG with other interventions, and did not separate of the results for CABG.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vraciu-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>Trial with non-relevant end-points.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CABG = coronary artery bypass graft</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-07-04 08:49:15 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-07-04 08:49:05 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 17:12:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crowe-1977">
<DESCRIPTION>
<P>"Quote: "..."subjects were assigned randomly to one of two treatment protocols using a computer-generated random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 17:17:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dull-1983">
<DESCRIPTION>
<P>"Quote: "... patients were randomly assigned to one of three exercise programs."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 17:19:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jenkins-1989">
<DESCRIPTION>
<P>Quote: "... Stratified randomisation to balance for age and forced expiratory ratio (FER) ..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 19:27:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matte-2000">
<DESCRIPTION>
<P>Quote: "...After extubation, patients were randomly assigned to 3 groups."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 19:51:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oikkonen-1991">
<DESCRIPTION>
<P>Quote: "... The patients were randomly allocates to receive IPPB or IS in addition to CPT."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-04 08:49:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romanini-2007">
<DESCRIPTION>
<P>Quote: "...The study was prospective and the patients were randomised by drawing lots, prior to the surgery, and divided into 2 groups: IPPB: 20 patients; Incentive Spirometry: 20 patients. (It was not necessary to change patients from the groups due to clinical criteria).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:36:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Savci-2006">
<DESCRIPTION>
<P>Quote: "... Eligible patients were randomly allocated to received either active cycle of breathing techniques or incentive spirometer."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-06-02 20:36:28 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:02:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Crowe-1977">
<DESCRIPTION>
<P>No description.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:02:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dull-1983">
<DESCRIPTION>
<P>No description.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 17:19:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jenkins-1989">
<DESCRIPTION>
<P>No description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 19:26:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matte-2000">
<DESCRIPTION>
<P>No description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 19:43:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oikkonen-1991">
<DESCRIPTION>
<P>No description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:22:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romanini-2007">
<DESCRIPTION>
<P>No description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:36:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Savci-2006">
<DESCRIPTION>
<P>No description</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2012-06-02 20:37:41 +0100" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 19:58:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crowe-1977">
<DESCRIPTION>
<P>Only the evaluator was blind, no information about the blinding of patient and the therapist.</P>
<P>Quote: "...These measurements were read and categorized by a single observer, who was blind to the treatment allocation of the patient."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:03:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dull-1983">
<DESCRIPTION>
<P>No information about the blinding of patients, therapist end evaluator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:06:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jenkins-1989">
<DESCRIPTION>
<P>No information about the blinding of patients, therapist end evaluator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:07:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matte-2000">
<DESCRIPTION>
<P>The evaluators were blind, but no information about the blinding of patient and the therapist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:08:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Oikkonen-1991">
<DESCRIPTION>
<P>No information about the blinding of patients, therapist end evaluator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:24:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Romanini-2007">
<DESCRIPTION>
<P>No information about the blinding of patients, therapist end evaluator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:37:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Savci-2006">
<DESCRIPTION>
<P>No information about the blinding of patients, therapist end evaluator.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-06-02 15:01:24 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2012-06-02 15:01:24 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-06-02 15:01:24 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-06-02 21:51:17 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-02 20:02:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Crowe-1977">
<DESCRIPTION>
<P>In some outcomes (e.g. Incidence of atelectasis, an evidence of pleural effusion, oxygen saturation) a smaller number of patients were evaluated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-02 21:51:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dull-1983">
<DESCRIPTION>
<P>No drop-outs reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-02 17:26:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jenkins-1989">
<DESCRIPTION>
<P>No drop-outs reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-02 19:25:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matte-2000">
<DESCRIPTION>
<P>No drop-outs reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-02 20:08:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oikkonen-1991">
<DESCRIPTION>
<P>No drop-outs reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-02 20:25:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romanini-2007">
<DESCRIPTION>
<P>No drop-outs reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-06-02 20:37:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Savci-2006">
<DESCRIPTION>
<P>No drop-outs reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-06-02 20:38:20 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 15:05:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Crowe-1977">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 16:48:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dull-1983">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 17:26:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jenkins-1989">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 19:24:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Matte-2000">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:09:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oikkonen-1991">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:30:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romanini-2007">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:38:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Savci-2006">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2012-06-02 15:05:41 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2012-07-04 08:48:00 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Intention to treat analysis</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:02:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Crowe-1977">
<DESCRIPTION>
<P>199 patients eligible to entry criteria, but only 185 were analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:02:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-1983">
<DESCRIPTION>
<P>49 patients eligible to entry criteria, 10 were eventually withdrawn from the study. However 49 subjects were analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 19:17:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jenkins-1989">
<DESCRIPTION>
<P>141 patients were considered for the study, however 110 patients were available for analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-04 08:48:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matte-2000">
<DESCRIPTION>
<P>Ninety-six patients undergoing elective CABG were included, six patients were excluded for non conformity with the study protocol, however 96 subjects were analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:17:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oikkonen-1991">
<DESCRIPTION>
<P>52 consecutive patients scheduled for CABG were select for the study, 9 were excluded (age older than 70 years, weight exceeding the ideal weight by more than 20 percent, history chronic obstructive pulmonary disease (COPD), thoracic anomalies, etc.), however 52 were analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:31:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romanini-2007">
<DESCRIPTION>
<P>Insufficient information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:38:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Savci-2006">
<DESCRIPTION>
<P>Insufficient information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2012-07-04 08:49:15 +0100" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Follow-up</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:02:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Crowe-1977">
<DESCRIPTION>
<P>Patients assessed in the preoperatively and postoperatively at first, second, and third days.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 16:47:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dull-1983">
<DESCRIPTION>
<P>Patients assessed four hours after extubation, and postoperative at first and second and third days. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-04 08:46:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jenkins-1989">
<DESCRIPTION>
<P>Quote: "...After surgery (which was performed via a median sternotomy) all patients were seen by a physiotherapist at least twice on days one and two and at least once daily on days three to five."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 19:39:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Matte-2000">
<DESCRIPTION>
<P>The patients were assessed in the preoperative, and postoperative at first and second days.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-04 08:47:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Oikkonen-1991">
<DESCRIPTION>
<P>The patients were assessed in the preoperative, and postoperative at one to seven days.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-06-02 20:33:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Romanini-2007">
<DESCRIPTION>
<P>The patients were assessed in the preoperative, and postoperative at first and second days.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-04 08:49:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Savci-2006">
<DESCRIPTION>
<P>The patients were assessed in the preoperative, and postoperative at one to five days.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2011-12-11 22:37:55 +0000" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES MODIFIED="2012-04-22 13:53:55 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2012-04-22 13:53:55 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-01-26 13:22:59 +0000" MODIFIED_BY="[Empty name]">Number of patients receiving Incentive Spirometry (IS) and other techniques included studies</TITLE>
<TABLE COLS="9" ROWS="9">
<TR>
<TD>
<P>
<B>Study</B>
</P>
</TD>
<TD>
<P>
<B>Incentive</B>
</P>
<P>
<B>Spirometry</B>
</P>
<P>
<B>(IS)</B>
</P>
</TD>
<TD>
<P>
<B>Physical</B>
</P>
<P>
<B>Therapy</B>
</P>
<P>
<B>(PT)</B>
</P>
</TD>
<TD>
<P>
<B>Continuous</B>
</P>
<P>
<B>Positive</B>
</P>
<P>
<B>Airway</B>
</P>
<P>
<B>Pressure (CPAP</B>
</P>
</TD>
<TD>
<P>
<B>Non invasive</B>
</P>
<P>
<B>ventilation</B>
</P>
<P>
<B>support with</B>
</P>
<P>
<B>bilevel positive</B>
</P>
<P>
<B>airway pressure</B>
</P>
<P>
<B>(BiPAP)</B>
</P>
</TD>
<TD>
<P>
<B>Intermettente</B>
</P>
<P>
<B>positive</B>
</P>
<P>
<B>pressure</B>
</P>
<P>
<B>breathing</B>
</P>
<P>
<B>(IPPB)</B>
</P>
</TD>
<TD>
<P>
<B>Active cycle</B>
</P>
<P>
<B>of breathing</B>
</P>
<P>
<B>techniques</B>
</P>
<P>
<B>(ACBT)</B>
</P>
</TD>
<TD>
<P>
<B>None</B>
</P>
</TD>
<TD>
<P>
<B>Total</B>
</P>
<P>
<B>patients of</B>
</P>
<P>
<B>study</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>17</P>
</TD>
<TD ALIGN="CENTER">
<P>16</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>16</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>49</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>38</P>
</TD>
<TD ALIGN="CENTER">
<P>35</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>37</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>110</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>26</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>26</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>
<B>52</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>90</P>
</TD>
<TD ALIGN="CENTER">
<P>95</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>
<B>185</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>30</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>33</P>
</TD>
<TD ALIGN="CENTER">
<P>33</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>
<B>96</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>30</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>30</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>
<B>60</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>
</P>
</TD>
<TD ALIGN="CENTER">
<P>20</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>20</P>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P/>
</TD>
<TD ALIGN="CENTER">
<P>
<B>40</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Total patients</B>
</P>
<P>
<B>of techniques</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>251</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>146</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>33</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>33</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>46</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>30</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>53</B>
</P>
</TD>
<TD ALIGN="CENTER">
<P>
<B>592</B>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2012-04-22 13:53:55 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE>Summary of primary outcomes of included trials</TITLE>
<TABLE COLS="3" ROWS="12">
<TR>
<TH>
<P>Study</P>
</TH>
<TH ALIGN="CENTER">
<P>Intervention (IS)</P>
<P>Peto Odds Ratio</P>
<P>Peto, Fixed, 95% CI</P>
</TH>
<TH ALIGN="CENTER">
<P>Control Group</P>
<P>Peto Odds Ratio</P>
<P>Peto, Fixed, 95% CI</P>
</TH>
</TR>
<TR>
<TD ALIGN="CENTER" COLSPAN="3">
<P>
<B>Atelectasis</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>
</P>
</TD>
<TD>
<P>60.5% (23/38)</P>
</TD>
<TD>
<P>(Conventional physical therapy) 54.3% (19/35); (Preoperative advice only) 64.9% (24/37)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>
</P>
</TD>
<TD>
<P>80.7% (21/26)</P>
</TD>
<TD>
<P>(IPPB) 61.5% (16/26)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>
</P>
</TD>
<TD>
<P>10.1% (9/89)</P>
</TD>
<TD>
<P>(Conventional Physical Therapy) 10.5% (10/95)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>
</P>
</TD>
<TD>
<P>30.0% (9/30)</P>
</TD>
<TD>
<P>(CPAP) 15.2% (5/33); (BiPAP) 15.2% (5/33)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>
</P>
</TD>
<TD>
<P>30.0% (9/30)</P>
</TD>
<TD>
<P>(ACBT) 33.3% (10/30)</P>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER" COLSPAN="3">
<P>
<B>Pneumonia</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>
</P>
</TD>
<TD>
<P>5.3% (2/38)</P>
</TD>
<TD>
<P>(Conventional physical therapy) 11.4% (4/35); (Preoperative advice only) 13.5% (5/37)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>
</P>
</TD>
<TD>
<P>38.5% (10/26)</P>
</TD>
<TD>
<P>(IPPB) 23.1% (6/26)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>
</P>
</TD>
<TD>
<P>8.9% (8/90)</P>
</TD>
<TD>
<P>(Conventional physical therapy) 10.5% (10/95)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>
</P>
</TD>
<TD>
<P>3.3% (1/30)</P>
</TD>
<TD>
<P>(CPAP) 3.0% (1/33); (BiPAP) 0.0% (0/30)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2012-04-22 13:53:55 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE>Summary of secondary outcomes of included trials</TITLE>
<TABLE COLS="2" ROWS="19">
<TR>
<TH>
<P>Study</P>
</TH>
<TH ALIGN="CENTER">
<P>
<B>Mean difference (IS <I>vs</I> control group)</B>
</P>
<P>
<B>IV, fixed, 95% CI</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="CENTER" COLSPAN="2">
<P>
<B>Vital capacity (ml)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>
</P>
</TD>
<TD>
<P>(Conventional physical therapy) 280.00 [-16.96, 576.96]; (Preoperative advice only) -65.00 [-521.76; 391.74]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>
</P>
</TD>
<TD>
<P>(Conventional physical therapy) 100.00 [-175.51, 375.51]; (Preoperative advice only) 0.0 [-277.29, 277.29]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>
</P>
</TD>
<TD>
<P>(IPPB) -272.00 [-350.68, -193.32]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>
</P>
</TD>
<TD>
<P>Standard deviation not available</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>
</P>
</TD>
<TD>
<P>(CPAP) -338.00 [-607.33, -68.67]; (BiPAP) -427.0 [-655.04, -198.96]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>
</P>
</TD>
<TD>
<P>Results presented as percentage</P>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER" COLSPAN="2">
<P>
<B>Forced expiratory volume in 1 second (ml)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Dull-1983" TYPE="STUDY">Dull 1983</LINK>
</P>
</TD>
<TD>
<P>(Preoperative advice only) 50.00 [-278.15, 378.15]; (Conventional physical therapy) 160.00 [-99.51, 419.51]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>
</P>
</TD>
<TD>
<P>(Conventional physical therapy) 0.0 [-184.16, 184.16]; (Preoperative advice only) 0.0 [-203.70, 203.70];</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Crowe-1977" TYPE="STUDY">Crowe 1977</LINK>
</P>
</TD>
<TD>
<P>(Conventional physical therapy) 55.00 [-22.84, 132.84]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>
</P>
</TD>
<TD>
<P>(CPAP) -183.0 [-310.09, -55.91];(BiPAP) -213.0 [-369.12, -56.88]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>
</P>
</TD>
<TD>
<P>Results presented as percentage</P>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER" COLSPAN="2">
<P>
<B>Arterial oxygenation (PaO2/FiO2) (mmHg)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Jenkins-1989" TYPE="STUDY">Jenkins 1989</LINK>
</P>
</TD>
<TD>
<P>(Preoperative advice only) 5.0 [-13.38, 23.38]; (Conventional physical therapy) -5.0 [-23.68, 13.68]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Oikkonen-1991" TYPE="STUDY">Oikkonen 1991</LINK>
</P>
</TD>
<TD>
<P>(IPPB) -35.0 [-54.57, -15.43]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Matte-2000" TYPE="STUDY">Matte 2000</LINK>
</P>
</TD>
<TD>
<P>(CPAP) -14.00 [-35.26, 7.26]; (BiPAP) -29.00 [-53.8, -4.20]</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>
</P>
</TD>
<TD>
<P>(ACBT) 2.00 [-39.49, 43.49}</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2012-04-22 13:53:55 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2010-12-23 18:27:57 +0000" MODIFIED_BY="[Empty name]">Summary of secondary outcomes of included trials</TITLE>
<TABLE COLS="2" ROWS="7">
<TR>
<TH>
<P>Study</P>
</TH>
<TH ALIGN="CENTER">
<P>
<B>Means difference (IS <I>vs</I> control group)</B>
</P>
<P>
<B>IV, fixed, 95% CI </B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="CENTER" COLSPAN="2">
<P>
<B>Maximum inspiratory pressure (MIP) (cmH<SUB>2</SUB>O)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>
</P>
</TD>
<TD>
<P>(IPPB) 17.40 [0.61, 34.19]</P>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER" COLSPAN="2">
<P>
<B>Maximum expiratory pressure (MEP) (cmH<SUB>2</SUB>O)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Romanini-2007" TYPE="STUDY">Romanini 2007</LINK>
</P>
</TD>
<TD>
<P>(IPPB) 12.75 [-0.99, 26.49]</P>
</TD>
</TR>
<TR>
<TD ALIGN="CENTER" COLSPAN="2">
<P>
<B>Six-minute walk test (6MWT) (mt)</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Savci-2006" TYPE="STUDY">Savci 2006</LINK>
</P>
</TD>
<TD>
<P>(ACBT)) -13.73 [-59,43, 31.97]</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-06-13 04:10:10 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-06-13 04:10:10 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Atelectasis</NAME>
<DICH_OUTCOME CHI2="0.19293270006153365" CI_END="2.156998939694899" CI_START="0.575029810313743" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.113704938994033" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="29" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.3338499316186472" LOG_CI_START="-0.24030964032049848" LOG_EFFECT_SIZE="0.046770145649074384" METHOD="PETO" MODIFIED="2012-06-02 21:56:57 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6604868918571684" P_Q="1.0" P_Z="0.7494905144143744" Q="0.0" RANDOM="NO" SCALE="194.52967155393398" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="127" TOTAL_2="130" WEIGHT="100.0" Z="0.3193112350780219">
<NAME>Incentive spirometry versus conventional physical therapy</NAME>
<GROUP_LABEL_1>Experimental group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4672848998737993" CI_START="0.37081883123159554" EFFECT_SIZE="0.9565122596634956" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.39221930080678974" LOG_CI_START="-0.43083821926241855" LOG_EFFECT_SIZE="-0.01930945922781439" MODIFIED="2010-12-17 21:33:56 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="-0.19021739130434767" SE="0.48346806148908517" STUDY_ID="STD-Crowe-1977" TOTAL_1="89" TOTAL_2="95" VAR="4.278232882177941" WEIGHT="48.663668414432365"/>
<DICH_DATA CI_END="3.236552354697713" CI_START="0.5113713758946604" EFFECT_SIZE="1.286499215225906" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="19" LOG_CI_END="0.5100826365887451" LOG_CI_START="-0.2912635853415836" LOG_EFFECT_SIZE="0.10940952562358071" MODIFIED="2010-12-17 21:30:53 +0000" MODIFIED_BY="[Empty name]" ORDER="5" O_E="1.1369863013698627" SE="0.4707147374896482" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="35" VAR="4.513198223556639" WEIGHT="51.33633158556763"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.5779663313995655" CI_START="0.7158133869544415" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.3290362268341487" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.8795526713902987" LOG_CI_START="-0.14520018380843658" LOG_EFFECT_SIZE="0.36717624379093106" METHOD="PETO" MODIFIED="2010-12-18 21:50:24 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.16015867468979003" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0" Z="1.4045380994217538">
<NAME>Incentive spirometry versus continuous positive airway pressure (CPAP)</NAME>
<GROUP_LABEL_1>Experimental group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.5779663313995655" CI_START="0.7158133869544415" EFFECT_SIZE="2.3290362268341487" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.8795526713902987" LOG_CI_START="-0.14520018380843658" LOG_EFFECT_SIZE="0.36717624379093106" MODIFIED="2010-12-17 21:39:05 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="2.333333333333333" SE="0.6019448997521802" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" VAR="2.759856630824373" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.5779663313995655" CI_START="0.7158133869544415" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.3290362268341487" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.8795526713902987" LOG_CI_START="-0.14520018380843658" LOG_EFFECT_SIZE="0.36717624379093106" METHOD="PETO" MODIFIED="2010-12-17 21:43:46 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.16015867468979003" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0" Z="1.4045380994217538">
<NAME>incentive spirometry versus bilevel positive airway pressure (BiPAP or NIV-2P)</NAME>
<GROUP_LABEL_1>Experimental group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.5779663313995655" CI_START="0.7158133869544415" EFFECT_SIZE="2.3290362268341487" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="5" LOG_CI_END="0.8795526713902987" LOG_CI_START="-0.14520018380843658" LOG_EFFECT_SIZE="0.36717624379093106" MODIFIED="2010-12-17 21:43:46 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="2.333333333333333" SE="0.6019448997521802" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" VAR="2.759856630824373" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.225122261006744" CI_START="0.7638717860056365" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.5065791093899152" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.9151423621704557" LOG_CI_START="-0.11697953056447949" LOG_EFFECT_SIZE="0.3990814158029881" METHOD="PETO" MODIFIED="2010-12-17 21:45:11 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.12959933292922635" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="26" WEIGHT="100.0" Z="1.5156837721956704">
<NAME>Incentive spirometry versus Intermittente positive pressure breathing (IPPB)</NAME>
<GROUP_LABEL_1>Experimental group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.225122261006744" CI_START="0.7638717860056368" EFFECT_SIZE="2.5065791093899152" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="16" LOG_CI_END="0.9151423621704557" LOG_CI_START="-0.11697953056447936" LOG_EFFECT_SIZE="0.3990814158029881" MODIFIED="2010-12-17 21:45:11 +0000" MODIFIED_BY="[Empty name]" ORDER="9" O_E="2.5" SE="0.6062735088782681" STUDY_ID="STD-Oikkonen-1991" TOTAL_1="26" TOTAL_2="26" VAR="2.7205882352941178" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.5277002625599176" CI_START="0.29221588858099046" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8594382923109426" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.4027255735525751" LOG_CI_START="-0.5342961739751263" LOG_EFFECT_SIZE="-0.06578530021127561" METHOD="PETO" MODIFIED="2012-06-13 04:10:10 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.7831582802401756" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0" Z="0.275205606415114">
<NAME>Incentive spirometry versus active cycle of breathing techniques</NAME>
<GROUP_LABEL_1>Experimental group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5277002625599176" CI_START="0.29221588858099046" EFFECT_SIZE="0.8594382923109426" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="10" LOG_CI_END="0.4027255735525751" LOG_CI_START="-0.5342961739751263" LOG_EFFECT_SIZE="-0.06578530021127561" MODIFIED="2010-12-20 20:18:24 +0000" MODIFIED_BY="[Empty name]" ORDER="26" O_E="-0.5" SE="0.5504112128302281" STUDY_ID="STD-Savci-2006" TOTAL_1="30" TOTAL_2="30" VAR="3.3008474576271185" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.109914567417728" CI_START="0.3287068671574457" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.8327925356448259" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.3242648706293456" LOG_CI_START="-0.48319122278959004" LOG_EFFECT_SIZE="-0.07946317608012221" METHOD="PETO" MODIFIED="2012-06-13 04:10:10 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.6996692274676697" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="37" WEIGHT="100.0" Z="0.3857670144137445">
<NAME>Incentive spirometry versus preoperative physiotherapy advice only</NAME>
<GROUP_LABEL_1>Experimental group</GROUP_LABEL_1>
<GROUP_LABEL_2>Control group</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.109914567417728" CI_START="0.3287068671574457" EFFECT_SIZE="0.8327925356448259" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.3242648706293456" LOG_CI_START="-0.48319122278959004" LOG_EFFECT_SIZE="-0.07946317608012221" MODIFIED="2010-12-18 21:48:51 +0000" MODIFIED_BY="[Empty name]" ORDER="11" O_E="-0.8133333333333326" SE="0.4743037062464076" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="37" VAR="4.445155555555556" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2011-05-16 21:23:20 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Pneumonia</NAME>
<DICH_OUTCOME CHI2="0.400192689494276" CI_END="1.6392747636752145" CI_START="0.3069526422538362" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.7093516195020211" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.2146517530500148" LOG_CI_START="-0.5129286238529234" LOG_EFFECT_SIZE="-0.14913843540145427" METHOD="PETO" MODIFIED="2010-12-18 22:01:46 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5269901817162834" P_Q="1.0" P_Z="0.42168493743682767" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="128" TOTAL_2="130" WEIGHT="100.0" Z="0.8035014999765406">
<NAME>Incentive spirometry versus conventional physical therapy</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1918697435561176" CI_START="0.314868559618628" EFFECT_SIZE="0.8307531938097898" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.34081474172124476" LOG_CI_START="-0.5018707025448712" LOG_EFFECT_SIZE="-0.08052798041181322" MODIFIED="2010-12-18 21:58:11 +0000" MODIFIED_BY="[Empty name]" ORDER="13" O_E="-0.7567567567567561" SE="0.4949976013221405" STUDY_ID="STD-Crowe-1977" TOTAL_1="90" TOTAL_2="95" VAR="4.0812557563438885" WEIGHT="74.54713720865205"/>
<DICH_DATA CI_END="2.3495885741292413" CI_START="0.08488568020155178" EFFECT_SIZE="0.4465942501967024" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.3709918215788029" LOG_CI_START="-1.0711655669289184" LOG_EFFECT_SIZE="-0.3500868726750577" MODIFIED="2010-12-18 21:57:48 +0000" MODIFIED_BY="[Empty name]" ORDER="12" O_E="-1.1232876712328768" SE="0.8471303888036416" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="35" VAR="1.3934759492087319" WEIGHT="25.452862791347947"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.792748726199231" CI_START="0.0814572033459688" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.38214172441417243" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.2535194225948451" LOG_CI_START="-1.0890705045405087" LOG_EFFECT_SIZE="-0.4177755409728318" METHOD="PETO" MODIFIED="2010-12-18 22:01:26 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.22255235043650057" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="37" WEIGHT="100.0" Z="1.2197693389158548">
<NAME>Incentive spirometry versus preoperative physiotherapy advice only</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.792748726199231" CI_START="0.0814572033459688" EFFECT_SIZE="0.38214172441417243" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2535194225948451" LOG_CI_START="-1.0890705045405087" LOG_EFFECT_SIZE="-0.4177755409728318" MODIFIED="2010-12-18 22:01:26 +0000" MODIFIED_BY="[Empty name]" ORDER="14" O_E="-1.5466666666666669" SE="0.7886439691266303" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="37" VAR="1.6078222222222225" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="18.076777284868275" CI_START="0.06716591728179609" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.1018817213462222" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="1.2571210073256525" LOG_CI_START="-1.1728510497342912" LOG_EFFECT_SIZE="0.0421349787956807" METHOD="PETO" MODIFIED="2010-12-18 22:07:41 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.9458092269136182" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0" Z="0.0679703626129852">
<NAME>Incentive spirometry versus continuous positive airway pressure (CPAP)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="18.076777284868275" CI_START="0.06716591728179609" EFFECT_SIZE="1.1018817213462222" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2571210073256525" LOG_CI_START="-1.1728510497342912" LOG_EFFECT_SIZE="0.0421349787956807" MODIFIED="2010-12-18 22:07:41 +0000" MODIFIED_BY="[Empty name]" ORDER="15" O_E="0.04761904761904767" SE="1.4273776148726876" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" VAR="0.4908199839075415" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="413.3852242568678" CI_START="0.1613176454499686" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="8.16616991256765" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="2.616354949460138" LOG_CI_START="-0.7923181254664803" LOG_EFFECT_SIZE="0.9120184119968289" METHOD="PETO" MODIFIED="2010-12-18 22:08:20 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.29426611955214055" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0" Z="1.0488088481701516">
<NAME>incentive spirometry versus bilevel positive airway pressure (BiPAP or NIV-2P)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="413.3852242568678" CI_START="0.1613176454499686" EFFECT_SIZE="8.16616991256765" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.616354949460138" LOG_CI_START="-0.7923181254664803" LOG_EFFECT_SIZE="0.9120184119968289" MODIFIED="2010-12-18 22:08:20 +0000" MODIFIED_BY="[Empty name]" ORDER="16" O_E="0.5238095238095238" SE="2.002271437415744" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" VAR="0.24943310657596374" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.519157891443211" CI_START="0.6324977958705327" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="2.030604096634748" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.8141914996093131" LOG_CI_START="-0.19894098357970647" LOG_EFFECT_SIZE="0.3076252580148034" METHOD="PETO" MODIFIED="2010-12-18 22:09:04 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.2339528548338059" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="26" WEIGHT="100.0" Z="1.1902380714238083">
<NAME>Incentive spirometry versus Intermittente positive pressure breathing (IPPB)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.519157891443211" CI_START="0.6324977958705327" EFFECT_SIZE="2.030604096634748" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.8141914996093131" LOG_CI_START="-0.19894098357970647" LOG_EFFECT_SIZE="0.3076252580148034" MODIFIED="2010-12-18 22:09:04 +0000" MODIFIED_BY="[Empty name]" ORDER="17" O_E="2.0" SE="0.5951190357119042" STUDY_ID="STD-Oikkonen-1991" TOTAL_1="26" TOTAL_2="26" VAR="2.8235294117647056" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2012-06-02 21:59:30 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Vital capacity (ml)</NAME>
<CONT_OUTCOME CHI2="0.7585042283239951" CI_END="385.2367254026269" CI_START="-18.70797752999036" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="183.2643739363183" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2012-06-02 21:59:09 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.38379706173486927" P_Q="1.0" P_Z="0.07533497891240504" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="142" TOTAL_2="149" UNITS="" WEIGHT="100.00000000000001" Z="1.7784195210718345">
<NAME>Incentive spirometry versus conventional physical therapy</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="1547.0" MEAN_2="1327.0" MODIFIED="2012-06-01 19:20:31 +0100" MODIFIED_BY="[Empty name]" ORDER="31" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Crowe-1977" TOTAL_1="90" TOTAL_2="95" WEIGHT="0.0"/>
<CONT_DATA CI_END="576.9604166426218" CI_START="-16.960416642621794" EFFECT_SIZE="280.0" ESTIMABLE="YES" MEAN_1="1980.0" MEAN_2="1700.0" MODIFIED="2011-12-22 14:32:39 +0000" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="510.0" SD_2="350.0" SE="151.5132007450176" STUDY_ID="STD-Dull-1983" TOTAL_1="17" TOTAL_2="16" WEIGHT="46.25798552017682"/>
<CONT_DATA CI_END="375.5084674651465" CI_START="-175.5084674651465" EFFECT_SIZE="100.0" ESTIMABLE="YES" MEAN_1="2200.0" MEAN_2="2100.0" MODIFIED="2012-06-01 19:20:24 +0100" MODIFIED_BY="[Empty name]" ORDER="27" SD_1="600.0" SD_2="600.0" SE="140.56812759740595" STUDY_ID="STD-Jenkins-1989" TOTAL_1="35" TOTAL_2="38" WEIGHT="53.7420144798232"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.7111403205567398E-31" CI_END="-68.6695421725949" CI_START="-607.3304578274052" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-338.00000000000006" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2010-12-26 22:04:34 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.01390593821292398" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" UNITS="" WEIGHT="100.0" Z="2.459684033207515">
<NAME>Incentive spirometry versus continuous positive airway pressure (CPAP)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-68.66954217259484" CI_START="-607.3304578274051" EFFECT_SIZE="-338.0" ESTIMABLE="YES" MEAN_1="1332.0" MEAN_2="1670.0" MODIFIED="2010-12-26 22:04:34 +0000" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="398.0" SD_2="670.0" SE="137.4160239432201" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.3868809513098723E-31" CI_END="-198.95901799506532" CI_START="-655.0409820049348" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-427.00000000000006" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-003.03" MODIFIED="2010-12-26 22:05:44 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="1.0" P_Z="2.4257453065015632E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" UNITS="" WEIGHT="100.0" Z="3.669974642454806">
<NAME>incentive spirometry versus bilevel positive airway pressure (BiPAP or NIV-2P)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-198.95901799506527" CI_START="-655.0409820049347" EFFECT_SIZE="-427.0" ESTIMABLE="YES" MEAN_1="1332.0" MEAN_2="1759.0" MODIFIED="2010-12-26 22:05:44 +0000" MODIFIED_BY="[Empty name]" ORDER="33" SD_1="398.0" SD_2="522.0" SE="116.34957774923055" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.05704398848562638" CI_END="218.57192181404014" CI_START="-253.2536110541156" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-17.34084462003773" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.04" MODIFIED="2012-06-02 21:59:30 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8112305586277024" P_Q="1.0" P_Z="0.8854469391552693" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="55" TOTAL_2="51" UNITS="" WEIGHT="100.00000000000001" Z="0.14406779010103452">
<NAME>Incentive spirometry versus preoperative physiotherapy advice only</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="391.7441549503621" CI_START="-521.7441549503621" EFFECT_SIZE="-65.0" ESTIMABLE="YES" MEAN_1="1980.0" MEAN_2="2045.0" MODIFIED="2011-12-21 18:54:59 +0000" MODIFIED_BY="[Empty name]" ORDER="36" SD_1="510.0" SD_2="790.0" SE="233.037014227354" STUDY_ID="STD-Dull-1983" TOTAL_1="17" TOTAL_2="16" WEIGHT="26.678222492365737"/>
<CONT_DATA CI_END="275.5084674651465" CI_START="-275.5084674651465" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="2200.0" MEAN_2="2200.0" MODIFIED="2011-12-21 18:55:38 +0000" MODIFIED_BY="[Empty name]" ORDER="34" SD_1="600.0" SD_2="600.0" SE="140.56812759740595" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="35" WEIGHT="73.32177750763428"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-193.32301706153163" CI_START="-350.67698293846837" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-272.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.05" MODIFIED="2010-12-26 22:07:49 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="1.2360335977914607E-11" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="26" UNITS="" WEIGHT="100.0" Z="6.775936034708261">
<NAME>Incentive spirometry versus Intermittente positive pressure breathing (IPPB)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-193.32301706153163" CI_START="-350.67698293846837" EFFECT_SIZE="-272.0" ESTIMABLE="YES" MEAN_1="1441.0" MEAN_2="1713.0" MODIFIED="2010-12-26 22:07:49 +0000" MODIFIED_BY="[Empty name]" ORDER="35" SD_1="114.0" SD_2="170.0" SE="40.14205544543796" STUDY_ID="STD-Oikkonen-1991" TOTAL_1="26" TOTAL_2="26" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2011-05-16 21:30:58 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Arterial oxygenation (PaO2/FiO2)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="23.38326828966256" CI_START="-13.38326828966256" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2011-05-16 21:12:28 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5939756725656203" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="37" UNITS="" WEIGHT="100.0" Z="0.5330836589166787">
<NAME>Incentive spirometry versus preoperative physiotherapy advice only</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_DATA CI_END="23.38326828966256" CI_START="-13.38326828966256" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="305.0" MEAN_2="300.0" MODIFIED="2011-05-16 21:03:48 +0100" MODIFIED_BY="[Empty name]" ORDER="25" SD_1="38.0" SD_2="43.0" SE="9.379390863642104" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="37" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="13.679245618743067" CI_START="-23.679245618743067" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2011-05-16 21:06:12 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.5998356914014499" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="38" TOTAL_2="35" UNITS="" WEIGHT="99.99999999999999" Z="0.5246368147152028">
<NAME>Incentive spirometry versus conventional physical therapy</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="13.679245618743067" CI_START="-23.679245618743067" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="305.0" MEAN_2="310.0" MODIFIED="2011-05-16 21:06:12 +0100" MODIFIED_BY="[Empty name]" ORDER="26" SD_1="38.0" SD_2="43.0" SE="9.530402479883596" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="35" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="7.260291949642582" CI_START="-35.26029194964258" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-14.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2011-05-16 21:09:03 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.1968267018777275" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" UNITS="" WEIGHT="100.0" Z="1.2906452953964285">
<NAME>Incentive spirometry versus continuous positive airway pressure (CPAP)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.260291949642578" CI_START="-35.26029194964258" EFFECT_SIZE="-14.0" ESTIMABLE="YES" MEAN_1="300.0" MEAN_2="314.0" MODIFIED="2011-05-16 21:09:03 +0100" MODIFIED_BY="[Empty name]" ORDER="27" SD_1="43.0" SD_2="43.0" SE="10.84728705085453" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.884278671878973E-32" CI_END="-4.201391287898652" CI_START="-53.798608712101355" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-29.000000000000004" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-004.04" MODIFIED="2011-05-16 21:15:05 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="1.0" P_Z="0.021904376474155177" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" UNITS="" WEIGHT="100.0" Z="2.2920219521801246">
<NAME>incentive spirometry versus bilevel positive airway pressure (BiPAP or NIV-2P)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_DATA CI_END="-4.201391287898648" CI_START="-53.798608712101355" EFFECT_SIZE="-29.0" ESTIMABLE="YES" MEAN_1="300.0" MEAN_2="329.0" MODIFIED="2011-05-16 21:10:04 +0100" MODIFIED_BY="[Empty name]" ORDER="28" SD_1="43.0" SD_2="57.0" SE="12.65258387792307" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-15.430536677262499" CI_START="-54.569463322737505" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-35.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.05" MODIFIED="2011-05-16 21:29:35 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="4.559267500233488E-4" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="26" UNITS="" WEIGHT="100.0" Z="3.505397073367767">
<NAME>Incentive spirometry versus Intermittente positive pressure breathing (IPPB)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-15.430536677262499" CI_START="-54.569463322737505" EFFECT_SIZE="-35.0" ESTIMABLE="YES" MEAN_1="357.0" MEAN_2="392.0" MODIFIED="2011-05-16 21:29:35 +0100" MODIFIED_BY="[Empty name]" ORDER="29" SD_1="36.0" SD_2="36.0" SE="9.984603532054125" STUDY_ID="STD-Oikkonen-1991" TOTAL_1="26" TOTAL_2="26" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="43.486161551755124" CI_START="-39.486161551755124" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.06" MODIFIED="2011-05-16 21:30:58 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.9247218296434943" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.0944876031538828">
<NAME>Incentive spirometry versus active cycle of breathing techniques</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="43.486161551755124" CI_START="-39.486161551755124" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="362.0" MEAN_2="360.0" MODIFIED="2011-05-16 21:30:58 +0100" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="65.0" SD_2="96.0" SE="21.166797899855645" STUDY_ID="STD-Savci-2006" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2011-07-15 16:19:46 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Maximum inspiratory pressure (MIP)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="34.19318027061183" CI_START="0.6068197293881674" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="17.4" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2011-05-16 21:50:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.04227659939957702" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="100.0" Z="2.0307870684076472">
<NAME>Incentive spirometry versus Intermittente positive pressure breathing (IPPB)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="34.19318027061183" CI_START="0.6068197293881674" EFFECT_SIZE="17.4" ESTIMABLE="YES" MEAN_1="63.9" MEAN_2="46.5" MODIFIED="2011-05-16 21:50:15 +0100" MODIFIED_BY="[Empty name]" ORDER="31" SD_1="29.37" SD_2="24.61" SE="8.568106558627758" STUDY_ID="STD-Romanini-2007" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2011-05-16 21:49:14 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>maximum expiratory pressure (MEP)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="26.487871188420893" CI_START="-0.9878711884208933" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="12.75" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2011-05-16 21:49:14 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.06890750874839624" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="100.0" Z="1.8190257034836943">
<NAME>Incentive spirometry versus Intermittente positive pressure breathing (IPPB)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="26.487871188420893" CI_START="-0.9878711884208933" EFFECT_SIZE="12.75" ESTIMABLE="YES" MEAN_1="64.25" MEAN_2="51.5" MODIFIED="2011-05-16 21:49:14 +0100" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="26.02" SD_2="17.48" SE="7.009246749829828" STUDY_ID="STD-Romanini-2007" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2011-05-16 21:51:08 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Six-minute walk test (6MWT)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="31.970000299865553" CI_START="-59.43000029986559" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-13.730000000000018" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2011-05-16 21:51:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5559639546659343" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="30" UNITS="" WEIGHT="100.0" Z="0.5888469437890603">
<NAME>Incentive spirometry versus active cycle of breathing techniques</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="31.970000299865553" CI_START="-59.43000029986559" EFFECT_SIZE="-13.730000000000018" ESTIMABLE="YES" MEAN_1="455.27" MEAN_2="469.0" MODIFIED="2011-05-16 21:51:08 +0100" MODIFIED_BY="[Empty name]" ORDER="33" SD_1="56.85" SD_2="114.36" SE="23.316755134452134" STUDY_ID="STD-Savci-2006" TOTAL_1="30" TOTAL_2="30" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2012-06-02 22:00:14 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Forcede expiratory volume in one second (ml)</NAME>
<CONT_OUTCOME CHI2="0.9714414807197147" CI_END="123.81235301479674" CI_START="-14.409358499469796" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="54.70149725766347" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.01" MODIFIED="2012-06-02 21:59:54 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6152536487792678" P_Q="1.0" P_Z="0.12082532200274297" Q="0.0" RANDOM="NO" SCALE="555.4109825472357" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="145" TOTAL_2="146" UNITS="" WEIGHT="99.99999999999999" Z="1.5513187233884163">
<NAME>Incentive spirometry versus conventional physical therapy</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="132.84212121041537" CI_START="-22.84212121041537" EFFECT_SIZE="55.0" ESTIMABLE="YES" MEAN_1="1045.0" MEAN_2="990.0" MODIFIED="2011-12-22 14:39:50 +0000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="270.0" SD_2="270.0" SE="39.71609775711395" STUDY_ID="STD-Crowe-1977" TOTAL_1="90" TOTAL_2="95" WEIGHT="78.82486165138013"/>
<CONT_DATA CI_END="419.5075387137277" CI_START="-99.50753871372768" EFFECT_SIZE="160.0" ESTIMABLE="YES" MEAN_1="1480.0" MEAN_2="1320.0" MODIFIED="2011-12-22 14:40:15 +0000" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="435.0" SD_2="320.0" SE="132.40423842513945" STUDY_ID="STD-Dull-1983" TOTAL_1="17" TOTAL_2="16" WEIGHT="7.092389593377749"/>
<CONT_DATA CI_END="184.1630737847988" CI_START="-184.1630737847988" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1700.0" MEAN_2="1700.0" MODIFIED="2011-07-15 14:12:29 +0100" MODIFIED_BY="[Empty name]" ORDER="61" SD_1="450.0" SD_2="350.0" SE="93.9624785136123" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="35" WEIGHT="14.082748755242102"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.06437856210581194" CI_END="186.97656774926165" CI_START="-159.16008376684292" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="13.908241991209373" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.02" MODIFIED="2012-06-02 22:00:14 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7997046933384144" P_Q="1.0" P_Z="0.8748444692334673" Q="0.0" RANDOM="NO" SCALE="874.0859580073748" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="55" TOTAL_2="53" UNITS="" WEIGHT="100.0" Z="0.15750804355238712">
<NAME>Incentive spirometry versus preoperative physiotherapy advice only</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="378.14551690758356" CI_START="-278.14551690758356" EFFECT_SIZE="50.0" ESTIMABLE="YES" MEAN_1="1480.0" MEAN_2="1430.0" MODIFIED="2011-12-22 14:43:50 +0000" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="435.0" SD_2="520.0" SE="167.42425855574567" STUDY_ID="STD-Dull-1983" TOTAL_1="17" TOTAL_2="16" WEIGHT="27.816483982418745"/>
<CONT_DATA CI_END="203.70353991986343" CI_START="-203.70353991986343" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1700.0" MEAN_2="1700.0" MODIFIED="2011-07-15 14:17:36 +0100" MODIFIED_BY="[Empty name]" ORDER="64" SD_1="450.0" SD_2="450.0" SE="103.93228729030275" STUDY_ID="STD-Jenkins-1989" TOTAL_1="38" TOTAL_2="37" WEIGHT="72.18351601758125"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-55.90817007545857" CI_START="-310.09182992454146" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-183.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-008.03" MODIFIED="2011-07-15 14:19:24 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.004770145358831309" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" UNITS="" WEIGHT="100.0" Z="2.822159452608292">
<NAME>Incentive spirometry versus continuous positive airway pressure (CPAP)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-55.90817007545857" CI_START="-310.09182992454146" EFFECT_SIZE="-183.0" ESTIMABLE="YES" MEAN_1="884.0" MEAN_2="1067.0" MODIFIED="2011-07-15 14:19:24 +0100" MODIFIED_BY="[Empty name]" ORDER="65" SD_1="258.0" SD_2="256.0" SE="64.84396189268045" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.2731401981851506E-31" CI_END="-56.879414717119204" CI_START="-369.1205852828807" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-212.99999999999997" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-008.04" MODIFIED="2011-07-15 14:20:28 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="1.0" P_Z="0.007494402896810139" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="30" TOTAL_2="33" UNITS="" WEIGHT="100.0" Z="2.6740376866420124">
<NAME>incentive spirometry versus bilevel positive airway pressure (BiPAP or NIV-2P)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-56.87941471711923" CI_START="-369.12058528288077" EFFECT_SIZE="-213.0" ESTIMABLE="YES" MEAN_1="884.0" MEAN_2="1097.0" MODIFIED="2011-07-15 14:20:28 +0100" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="258.0" SD_2="369.0" SE="79.65482351427885" STUDY_ID="STD-Matte-2000" TOTAL_1="30" TOTAL_2="33" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-07-04 08:49:16 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-06-28 09:53:43 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Flow diagram.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-07-04 08:49:16 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2012-07-04 08:49:16 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2012-06-13 03:40:55 +0100" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Atelectasis, outcome: 1.1 Incentive spirometry versus conventional physical therapy.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2012-06-13 03:40:53 +0100" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-002.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Pneumonia, outcome: 2.1 Incentive spirometry versus conventional physical therapy.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2012-06-13 03:40:50 +0100" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-008.01" SETTINGS="SHOW_MORE_DECIMALS:NO;SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;SHOW_WEIGHT_COLUMN:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 Forcede expiratory volume in one second (ml), outcome: 8.1 Incentive spirometry versus conventional physical therapy.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-01-17 16:00:11 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2012-01-17 11:53:49 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-01-17 11:53:11 +0000" MODIFIED_BY="[Empty name]">Search strategies 2004</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-17 11:53:49 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL</HEADING>
<P>(Terms in capitals are exploded MeSH terms, those in lower case text words.)<BR/>1 CORONARY ARTERY BYPASS (ME exp)<BR/>2 MYOCARDIAL REVASCULARIZATION (ME)<BR/>3 CARDIAC SURGICAL PROCEDURES (ME)<BR/>4 THORACIC SURGERY (ME)<BR/>5 CARDIOPULMONARY BYPASS (ME)<BR/>6 (#1 or #2 or #3 or #4 or #5)<BR/>7 cabg<BR/>8 (coronary near bypass*)<BR/>9 (heart near bypass*)<BR/>10 (cardiopulmonary near bypass*)<BR/>11 (cardiac near surgery)<BR/>12 (heart near surgery)<BR/>13 (thora* near surgery)<BR/>14 (#7 or #8 or #9 or #10 or #11 or #12 or #13)<BR/>15 (#6 or #14)<BR/>16 SPIROMETRY (ME exp)<BR/>17 spiromet*<BR/>18 broncospiromet*<BR/>19 RESPIRATORY THERAPY (ME)<BR/>20 WORK OF BREATHING (ME)<BR/>21 bronco spirograph*<BR/>22 spirograph*<BR/>23 (lung next function)<BR/>24 PHYSICAL THERAPY TECHNIQUES (ME)<BR/>25 BREATHING EXERCISES (ME)<BR/>26 (#16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25)<BR/>27 (breath* near exercise*)<BR/>28 (breath* near measur*)<BR/>29 (incentive near breath*)<BR/>30 physiotherap*<BR/>31 triflo*<BR/>32 spirocare<BR/>33 (breath* near device*)<BR/>34 (respiratory next therapy)<BR/>35 (maxim* near inspira*)<BR/>36 coach<BR/>37 (#27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36)<BR/>38 (#26 or #37)<BR/>39 (#15 and #38)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE</HEADING>
<P>1 exp Coronary Artery Bypass/<BR/>2 myocardial revascularization/<BR/>3 Cardiac Surgical Procedures/<BR/>4 Thoracic Surgery/<BR/>5 Cardiopulmonary Bypass/<BR/>6 cabg.tw.<BR/>7 (coronary adj3 bypass$).tw.<BR/>8 (heart adj3 bypass$).tw.<BR/>9 (cardiopulmonary adj3 bypass$).tw.<BR/>10 cardiac surgery.tw.<BR/>11 heart surgery.tw.<BR/>12 thoracic surgery.tw.<BR/>13 or/1-12<BR/>14 exp Spirometry/<BR/>15 spiromet$.tw.<BR/>16 bronchospiromet$.tw.<BR/>17 Respiratory Therapy/<BR/>18 Work of Breathing/<BR/>19 bronchospirograph$.tw.<BR/>20 spirograph$.tw.<BR/>21 lung function.tw.<BR/>22 Physical Therapy Techniques/<BR/>23 Breathing Exercises/<BR/>24 (breath$ adj3 exercise$).tw.<BR/>25 (breath$ adj3 measur$).tw.<BR/>26 (incentive adj3 breath$).tw.<BR/>27 physiotherap$.tw.<BR/>28 exp Forced Expiratory Flow Rates/<BR/>29 spirocare.tw.<BR/>30 triflo.tw.<BR/>31 (breath$ adj3 device$).tw.<BR/>32 respiratory therap$.tw.<BR/>33 (maxim$ adj3 inspira$).tw.<BR/>34 coach.tw.<BR/>35 or/14-34<BR/>36 13 and 35</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE</HEADING>
<P>1 exp Coronary Artery Bypass/<BR/>2 exp Coronary artery surgery/<BR/>3 Heart Surgery/<BR/>4 Thorax Surgery/<BR/>5 Cardiopulmonary Bypass/<BR/>6 cabg.tw.<BR/>7 (coronary adj3 bypass$).tw.<BR/>8 (heart adj3 bypass$).tw.<BR/>9 (cardiopulmonary adj3 bypass$).tw.<BR/>10 cardiac surgery.tw.<BR/>11 heart surgery.tw.<BR/>12 thoracic surgery.tw.<BR/>13 or/1-12<BR/>14 exp Spirometry/<BR/>15 Spirography/<BR/>16 spiromet$.tw.<BR/>17 bronchospiromet$.tw.<BR/>18 exp Lung function test/<BR/>19 Bronchospirography/<BR/>20 bronchospirograph$.tw.<BR/>21 spirograph$.tw.<BR/>22 lung function.tw.<BR/>23 Physiotherapy/<BR/>24 Breathing Exercise/<BR/>25 (breath$ adj3 exercise$).tw.<BR/>26 (breath$ adj3 measur$).tw.<BR/>27 (incentive adj3 breath$).tw.<BR/>28 physiotherap$.tw.<BR/>29 Forced Expiratory Flow/<BR/>30 spirocare.tw.<BR/>31 triflo.tw.<BR/>32 (breath$ adj3 device$).tw.<BR/>33 respiratory therap$.tw.<BR/>34 (maxim$ adj3 inspira$).tw.<BR/>35 coach.tw.<BR/>36 or/14-35<BR/>37 13 and 36<BR/>38 controlled study/<BR/>39 clinical trial/<BR/>40 major clinical study<BR/>41 random$.tw.<BR/>42 randomized controlled trial/<BR/>43 trial.tw.<BR/>44 compar$.tw.<BR/>45 control$.tw.<BR/>46 follow-up.tw.<BR/>47 blind$.tw.<BR/>48 double blind procedure/<BR/>49 placebo$.tw.<BR/>50 clinical article/<BR/>51 placebo/<BR/>52 doubl$.tw.<BR/>53 or/38-52<BR/>54 37 and 53</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL</HEADING>
<P>1 exp Coronary Artery Bypass/<BR/>2 Heart Surgery/<BR/>3 Thorax Surgery/<BR/>4 Cardiopulmonary bypass/<BR/>5 cabg.tw.<BR/>6 (coronary adj3 bypass$.tw.<BR/>7 (heart adj bypass$).tw.<BR/>8 (cardiopulmonary adj3 bypass).tw.<BR/>9 cardiac surgery.tw.<BR/>10 heart surgery.tw.<BR/>11 thoracic surgery.tw.<BR/>12 or/1-11<BR/>13 exp spirometry/<BR/>14 spiromet$.tw.<BR/>15 bronchospiromet$.tw.<BR/>16 exp Respiratory Function tests/<BR/>17 bronchospirograph$.tw.<BR/>18 spirograph$.tw.<BR/>19 lung function.tw.<BR/>20 Physical Therapy/<BR/>21 Breathing Exercises/<BR/>22 (breath$ adj3 exercise$).tw.<BR/>23 (breath$ adj3 measur$).tw.<BR/>24 (incentive adj3 breath$).tw.<BR/>25 physiotherap$.tw.<BR/>26 exp respiratory airflow/<BR/>27 spirocare.tw.<BR/>28 triflo.tw.<BR/>29 (breath$ adj3 device$).tw.<BR/>30 respiratory therap$.tw.<BR/>31 (maxim$ adj3 inspira$).tw.<BR/>32 coach.tw.<BR/>33 or/13-32<BR/>34 12 and 33<BR/>35 experimental studies/<BR/>36 exp clinical trial/<BR/>37 ((control$ or clinic$ or prospective$) adj5 (trial$ or study or studies)).tw.<BR/>38 ((allocate$ or assign$ or divid$) adj5 (condition$ or experiment$ or treatment$ or control$ or group$)).tw.<BR/>39 ((singl$ or doubl$) adj (blind$ or mask$).tw.<BR/>40 cross?over$.tw.<BR/>41 placebo$.tw.<BR/>42 exp Clinical research/<BR/>43 comparative studies/<BR/>44 exp evaluation research/<BR/>45 exp "control (research)"/<BR/>46 Random assignment/<BR/>47 exp Prospective studies/<BR/>48 exp Evaluation research/<BR/>49 random$.tw.<BR/>50 RCT.tw.<BR/>51 (compare$ adj5 (trial$ or study$ or studies)).tw.<BR/>52 or/35-51<BR/>54 34 and 52<BR/>
</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2012-01-17 12:00:24 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-01-17 11:54:20 +0000" MODIFIED_BY="[Empty name]">Search strategies 2009/2011</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-17 12:00:24 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL and DARE</HEADING>
<P>#1MeSH descriptor Coronary Artery Bypass explode all trees<BR/>#2MeSH descriptor Myocardial Revascularization explode all trees<BR/>#3MeSH descriptor Cardiac Surgical Procedures explode all trees<BR/>#4MeSH descriptor THORACIC SURGERY this term only<BR/>#5MeSH descriptor CARDIOPULMONARY BYPASS this term only<BR/>#6(#1 or #2 or #3 or #4 or #5)<BR/>#7cabg in All Text<BR/>#8(coronary in All Text near/6 bypass* in All Text)<BR/>#9(heart in All Text near/6 bypass* in All Text)<BR/>#10(cardiopulmonary in All Text near/6 bypass* in All Text)<BR/>#11(cardiac in All Text near/6 surgery in All Text)<BR/>#12(heart in All Text near/6 surgery in All Text)<BR/>#13(thora* in All Text near/6 surgery in All Text)<BR/>#14(#7 or #8 or #9 or #10 or #11 or #12 or #13)<BR/>#15(#6 or #14)<BR/>#16MeSH descriptor Spirometry explode all trees<BR/>#17spiromet* in All Text<BR/>#18broncospiromet* in All Text<BR/>#19MeSH descriptor RESPIRATORY THERAPY this term only<BR/>#20MeSH descriptor WORK OF BREATHING this term only<BR/>#21broncospirograph* in All Text<BR/>#22spirograph* in All Text<BR/>#23lung next function in All Text<BR/>#24MeSH descriptor Physical Therapy Modalities this term only<BR/>#25MeSH descriptor BREATHING EXERCISES this term only<BR/>#26(#16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25)<BR/>#27(breath* in All Text near/6 exercise* in All Text)<BR/>#28(breath* in All Text near/6 measur* in All Text)<BR/>#29(incentive in All Text near/6 breath* in All Text)<BR/>#30physiotherap* in All Text<BR/>#31triflo* in All Text<BR/>#32spirocare in All Text<BR/>#33(breath* in All Text near/6 device* in All Text)<BR/>#34respiratory next therapy in All Text<BR/>#35(maxim* in All Text near/6 inspira* in All Text)<BR/>#36coach in All Text<BR/>#37(#27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36)<BR/>#38(#26 or #37)<BR/>#39(#15 and #38)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE 2009</HEADING>
<P>1 exp Coronary Artery Bypass/ (37737)<BR/>2 myocardial revascularization/ (7885)<BR/>3 Cardiac Surgical Procedures/ (27271)<BR/>4 Thoracic Surgery/ (8782)<BR/>5 Cardiopulmonary Bypass/ (16722)<BR/>6 cabg.tw. (8782)<BR/>7 (coronary adj3 bypass$).tw. (29412)<BR/>8 (heart adj3 bypass$).tw. (1448)<BR/>9 (cardiopulmonary adj3 bypass$).tw. (19821)<BR/>10 cardiac surgery.tw. (18250)<BR/>11 heart surgery.tw. (10445)<BR/>12 thoracic surgery.tw. (5077)<BR/>13 or/1-12 (112424)<BR/>14 exp Spirometry/ (15482)<BR/>15 spiromet$.tw. (11079)<BR/>16 bronchospiromet$.tw. (208)<BR/>17 Respiratory Therapy/ (5158)<BR/>18 Work of Breathing/ (1654)<BR/>19 bronchospirograph$.tw. (20)<BR/>20 spirograph$.tw. (613)<BR/>21 lung function.tw. (16247)<BR/>22 Physical Therapy Techniques/ (21768)<BR/>23 Breathing Exercises/ (2225)<BR/>24 (breath$ adj3 exercise$).tw. (1337)<BR/>25 (breath$ adj3 measur$).tw. (2763)<BR/>26 (incentive adj3 breath$).tw. (27)<BR/>27 physiotherap$.tw. (10077)<BR/>28 exp Forced Expiratory Flow Rates/ (8155)<BR/>29 spirocare.tw. (1)<BR/>30 triflo.tw. (13)<BR/>31 (breath$ adj3 device$).tw. (275)<BR/>32 respiratory therap$.tw. (1335)<BR/>33 (maxim$ adj3 inspira$).tw. (1752)<BR/>34 coach.tw. (754)<BR/>35 or/14-34 (82156)<BR/>36 13 and 35 (838)<BR/>37 randomized controlled trial.pt. (278858)<BR/>38 controlled clinical trial.pt. (80338)<BR/>39 Randomized controlled trials/ (62927)<BR/>40 random allocation/ (65783)<BR/>41 double blind method/ (103539)<BR/>42 single-blind method/ (13336)<BR/>43 or/37-42 (470716)<BR/>44 exp animal/ not humans/ (3440908)<BR/>45 43 not 44 (438732)<BR/>46 clinical trial.pt. (456939)<BR/>47 exp Clinical Trials as Topic/ (220960)<BR/>48 (clin$ adj25 trial$).ti,ab. (165102)<BR/>49 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab. (100603)<BR/>50 placebos/ (28372)<BR/>51 placebo$.ti,ab. (119070)<BR/>52 random$.ti,ab. (458323)<BR/>53 research design/ (57560)<BR/>54 or/46-53 (993616)<BR/>55 54 not 44 (920930)<BR/>56 45 or 55 (950392)<BR/>57 56 and 36 (189)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE 2011</HEADING>
<P>1. exp Coronary Artery Bypass/<BR/>2. Myocardial Revascularization/<BR/>3. Cardiac Surgical Procedures/<BR/>4. Thoracic Surgery/<BR/>5. Cardiopulmonary Bypass/<BR/>6. cabg.tw.<BR/>7. (coronary adj3 bypass$).tw.<BR/>8. (heart adj3 bypass$).tw.<BR/>9. (cardiopulmonary adj3 bypass$).tw.<BR/>10. cardiac surgery.tw.<BR/>11. heart surgery.tw.<BR/>12. thoracic surgery.tw.<BR/>13. or/1-12<BR/>14. exp Spirometry/<BR/>15. spiromet$.tw.<BR/>16. bronchospiromet$.tw.<BR/>17. Respiratory Therapy/<BR/>18. Work of Breathing/<BR/>19. bronchospirograph$.tw.<BR/>20. spirograph$.tw.<BR/>21. lung function.tw.<BR/>22. Physical Therapy Modalities/<BR/>23. Breathing Exercises/<BR/>24. (breath$ adj3 exercise$).tw.<BR/>25. (breath$ adj3 measur$).tw.<BR/>26. (incentive adj3 breath$).tw.<BR/>27. physiotherap$.tw.<BR/>28. exp Forced Expiratory Flow Rates/<BR/>29. spirocare.tw.<BR/>30. triflo.tw.<BR/>31. (breath$ adj3 device$).tw.<BR/>32. respiratory therap$.tw.<BR/>33. (maxim$ adj3 inspira$).tw.<BR/>34. coach.tw.<BR/>35. or/14-34<BR/>36. 13 and 35<BR/>37. randomized controlled trial.pt.<BR/>38. controlled clinical trial.pt.<BR/>39. randomized.ab.<BR/>40. placebo.ab.<BR/>41. drug therapy.fs.<BR/>42. randomly.ab.<BR/>43. trial.ab.<BR/>44. groups.ab.<BR/>45. 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44<BR/>46. exp animals/ not humans.sh.<BR/>47. 45 not 46<BR/>48. 36 and 47</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE 2009</HEADING>
<P>1 exp Coronary Artery Bypass/ <BR/>2 exp Coronary artery surgery/ <BR/>3 Heart Surgery/ <BR/>4 Thorax Surgery/ <BR/>5 Cardiopulmonary Bypass/ <BR/>6 cabg.tw. <BR/>7 (coronary adj3 bypass$).tw. <BR/>8 (heart adj3 bypass$).tw. <BR/>9 (cardiopulmonary adj3 bypass$).tw. <BR/>10 cardiac surgery.tw. <BR/>11 heart surgery.tw. <BR/>12 thoracic surgery.tw. <BR/>13 or/1-12 <BR/>14 exp Spirometry/ <BR/>15 Spirography/ <BR/>16 spiromet$.tw. <BR/>17 bronchospiromet$.tw. <BR/>18 exp Lung function test/ <BR/>19 Bronchospirography/ <BR/>20 bronchospirograph$.tw. <BR/>21 spirograph$.tw. <BR/>22 lung function.tw. <BR/>23 Physiotherapy/ <BR/>24 Breathing Exercise/ <BR/>25 (breath$ adj3 exercise$).tw. <BR/>26 (breath$ adj3 measur$).tw. <BR/>27 (incentive adj3 breath$).tw. <BR/>28 physiotherap$.tw. <BR/>29 Forced Expiratory Flow/<BR/>30 spirocare.tw. <BR/>31 triflo.tw. <BR/>32 (breath$ adj3 device$).tw. <BR/>33 respiratory therap$.tw. <BR/>34 (maxim$ adj3 inspira$).tw. <BR/>35 coach.tw. <BR/>36 or/14-35 <BR/>37 13 and 36 <BR/>38 controlled clinical trial/ <BR/>39 random$.tw. <BR/>40 randomized controlled trial/ <BR/>41 follow-up.tw. <BR/>42 double blind procedure/ <BR/>43 placebo$.tw. <BR/>44 placebo/ <BR/>45 factorial$.ti,ab. <BR/>46 (crossover$ or cross-over$).ti,ab. <BR/>47 (double$ adj blind$).ti,ab. <BR/>48 (singl$ adj blind$).ti,ab. <BR/>49 assign$.ti,ab. <BR/>50 allocat$.ti,ab. <BR/>51 volunteer$.ti,ab. <BR/>52 Crossover Procedure/ <BR/>53 Single Blind Procedure/ <BR/>54 or/38-53 <BR/>55 (exp animals/ or nonhuman/) not human/ <BR/>56 54 not 55 <BR/>57 37 and 56 </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">EMBASE 2011</HEADING>
<P>1. exp coronary artery bypass graft/<BR/>2. exp coronary artery surgery/<BR/>3. heart surgery/<BR/>4. thorax surgery/<BR/>5. cardiopulmonary bypass/<BR/>6. cabg.tw.<BR/>7. (coronary adj3 bypass$).tw.<BR/>8. (heart adj3 bypass$).tw.<BR/>9. (cardiopulmonary adj3 bypass$).tw.<BR/>10. cardiac surgery.tw.<BR/>11. heart surgery.tw.<BR/>12. thoracic surgery.tw.<BR/>13. or/1-12<BR/>14. exp spirometry/<BR/>15. spirography/<BR/>16. spiromet$.tw.<BR/>17. bronchospiromet$.tw.<BR/>18. exp lung function test/<BR/>19. bronchospirography/<BR/>20. bronchospirograph$.tw.<BR/>21. spirograph$.tw.<BR/>22. lung function.tw.<BR/>23. physiotherapy/<BR/>24. breathing exercise/<BR/>25. (breath$ adj3 exercise$).tw.<BR/>26. (breath$ adj3 measur$).tw.<BR/>27. (incentive adj3 breath$).tw.<BR/>28. physiotherap$.tw.<BR/>29. forced expiratory flow/<BR/>30. spirocare.tw.<BR/>31. triflo.tw.<BR/>32. (breath$ adj3 device$).tw.<BR/>33. respiratory therap$.tw.<BR/>34. (maxim$ adj3 inspira$).tw.<BR/>35. coach.tw.<BR/>36. or/14-35<BR/>37. 13 and 36<BR/>38. random$.tw.<BR/>39. factorial$.tw.<BR/>40. crossover$.tw.<BR/>41. cross over$.tw.<BR/>42. cross-over$.tw.<BR/>43. placebo$.tw.<BR/>44. (doubl$ adj blind$).tw.<BR/>45. (singl$ adj blind$).tw.<BR/>46. assign$.tw.<BR/>47. allocat$.tw.<BR/>48. volunteer$.tw.<BR/>49. crossover procedure/<BR/>50. double blind procedure/<BR/>51. randomized controlled trial/<BR/>52. single blind procedure/<BR/>53. 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52<BR/>54. (animal/ or nonhuman/) not human/<BR/>55. 53 not 54<BR/>56. 37 and 55<BR/>59. limit 56 to embase</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">AMED 2009</HEADING>
<P>1 exp Coronary Artery Bypass/ <BR/>2 myocardial revascularization/ <BR/>3 Heart Surgery/ <BR/>4 Thoracic Surgery/ <BR/>5 cabg.tw. <BR/>6 (coronary adj3 bypass$).tw. <BR/>7 (heart adj3 bypass$).tw. <BR/>8 (cardiopulmonary adj3 bypass$).tw.<BR/>9 cardiac surgery.tw. <BR/>10 heart surgery.tw. <BR/>11 thoracic surgery.tw. <BR/>12 or/1-11 <BR/>13 exp Spirometry/ <BR/>14 spiromet$.tw. <BR/>15 bronchospiromet$.tw. <BR/>16 Respiratory Therapy/ <BR/>17 bronchospirograph$.tw. <BR/>18 spirograph$.tw. <BR/>19 lung function.tw. <BR/>20 Physiotherapy/ <BR/>21 Breathing Exercises/ <BR/>22 (breath$ adj3 exercise$).tw. <BR/>23 (breath$ adj3 measur$).tw. <BR/>24 (incentive adj3 breath$).tw. <BR/>25 physiotherap$.tw. <BR/>26 exp Forced Expiratory Flow Rates/ <BR/>27 spirocare.tw. <BR/>28 triflo.tw. <BR/>29 (breath$ adj3 device$).tw. <BR/>30 respiratory therap$.tw. <BR/>31 (maxim$ adj3 inspira$).tw. <BR/>32 coach.tw. <BR/>33 or/13-32 <BR/>34 12 and 33 </P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">AMED 2011</HEADING>
<P>1 coronary artery bypass/<BR/>2 myocardial revascularization/<BR/>3 heart surgery/<BR/>4 thoracic surgery/<BR/>5 cabg.tw.<BR/>6 (coronary adj3 bypass*).tw.<BR/>7 (heart adj3 bypass*).tw.<BR/>8 (cardiopulmonary adj3 bypass*).tw.<BR/>9 cardiac surgery.tw.<BR/>10 heart surgery.tw.<BR/>11 thoracic surgery.tw.<BR/>12 or/1-11<BR/>13 spirometry/<BR/>14 spiromet*.tw.<BR/>15 bronchospiromet*.tw.<BR/>16 respiratory therapy/<BR/>17 bronchospirograph*.tw.<BR/>18 spirograph*.tw.<BR/>19 lung function.tw.<BR/>20 Physiotherapy/<BR/>21 breathing exercises/<BR/>22 (breath* adj3 exercise*).tw.<BR/>23 (breath* adj3 measur*).tw.<BR/>24 (incentive adj3 breath*).tw.<BR/>25 physiotherap*.tw.<BR/>26 exp forced expiratory flow rates/<BR/>27 spirocare.tw.<BR/>28 triflo.tw.<BR/>29 (breath* adj3 device*).tw.<BR/>30 respiratory therap*.tw.<BR/>31 (maxim* adj3 inspira*).tw.<BR/>32 coach.tw.<BR/>33 or/13-32<BR/>34 12 and 33</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL 2009</HEADING>
<P>( ( (MH "Coronary Artery Bypass+") or cabg or coronary surgery or cardiac surgery or coronary N5 bypass or heart N5 bypass ) ) and ( ( (MH "Spirometry") or spirometr* or bronchospirometr* or spirocare or triflow or coach or spirograph* or (MH "Chest Physical Therapy") or (MH "Rehabilitation, Pulmonary+") or physiotherap* ) )</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">CINAHL 2011</HEADING>
<P>S10 S3 and S9<BR/>S9 S4 or S5 or S6 or S7 or S8<BR/>S8 TI (physiotherap*) or AB (physiotherap*)<BR/>S7 MH "Rehabilitation, Pulmonary+"<BR/>S6 MH "Chest Physical Therapy"<BR/>S5 TI (spirometr* or bronchospirometr* or spirocare or triflow or coach or spirograph*) or AB (spirometr* or bronchospirometr* or spirocare or triflow or coach or spirograph*)<BR/>S4 MH "Spirometry"<BR/>S3 S1 or S2<BR/>S2 TI (cabg or coronary surgery or cardiac surgery or coronary N5 bypass or heart N5 bypass) or AB (cabg or coronary surgery or cardiac surgery or coronary N5 bypass or heart N5 bypass)<BR/>S1 MH "Coronary Artery Bypass+"<BR/>
</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;i&gt;7 (5 + 2) papers considered for inclusion:&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;i&gt;(Dull 1983, Jenkins 1989; Oikkonen 1991; Crowe 1997, Matte 2000, Savci 2006; Romanini 2007)&lt;/i&gt;&lt;/p&gt;&lt;p&gt;Pneumonia&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 04&lt;/p&gt;&lt;p&gt;Atelectasis&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 05&lt;/p&gt;&lt;p&gt;Postoperative days in hospital &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 02&lt;/p&gt;&lt;p&gt;Pulmonary function &amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 05&lt;/p&gt;&lt;p&gt;Partial arterial oxygenation&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 04&lt;/p&gt;&lt;p&gt;Ventilatory muscle strength&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 01&lt;/p&gt;&lt;p&gt;Functional capacity&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; 01&lt;/p&gt;" WIDTH="330">
<FLOWCHARTBOX TEXT="&lt;p&gt;19 (14 + 5) papers considered for inclusion:&lt;/p&gt;&lt;p&gt;&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;156 (143 + 13) papers retrieved for more detailed evaluation:&lt;/p&gt;&lt;p&gt;&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;1148 (782 + 366) potentially relevant publications identified and screened for retrieval.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;">
<OUT TEXT="&lt;p&gt;992 (639 + 353) papers excluded on the bias of title and abstract (generally due to lack of suitability of study design or intervention):&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="150"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;137 (129 +8) Papers not meeting inclusion criteria:&lt;/p&gt;&lt;p&gt;&lt;/p&gt;"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;12 papers excluded (details in table of excluded studies):&lt;/p&gt;&lt;p&gt;- Trials with non-relevant end points&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;i&gt;(Mahler 1998; Oulton 1981; Rau 1988; Vraciu 1977)&lt;/i&gt;&lt;/p&gt;&lt;p&gt;- Quasi-randomized trial&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &lt;i&gt;(I&lt;/i&gt;verson 1978)&lt;/p&gt;&lt;p&gt;- Non-controlled trials&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;i&gt;(Paul 1981)&lt;/i&gt;&lt;/p&gt;&lt;p&gt;- Inappropriate outcome data&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; &amp;#160;&amp;#160;&amp;#160;&lt;i&gt;(Gale 1980; Stock 1984; Renault 2009)&lt;/i&gt;&lt;/p&gt;&lt;p&gt;- Duplicated Controled Trial&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;i&gt;(Jenkins 1990)&lt;/i&gt;&lt;/p&gt;&lt;p&gt;- Connected IS with EPAP&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;i&gt;(Ferreira 2010; Haeffener 2008)&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="377"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>